SEC Info - Tyson Foods, Inc. - ‘10-K’ for 9/30/23

Sales

i 52,881

i 53,282

i 47,049

Cost of Sales

i 50,250

i 46,614

i 40,523

Gross Profit

i 2,631

i 6,668

i 6,526

Selling, General and Administrative

i 2,245

i 2,258

i 2,130

Goodwill Impairment

i 781

i —

Operating Income (Loss)

( i 395)

i 4,410

i 4,396

Other (Income) Expense:

Interest income

( i 30)

( i 17)

( i 8)

Interest expense

i 355

i 365

i 428

Other, net

( i 42)

( i 87)

( i 65)

Total Other (Income) Expense

i 283

i 261

i 355

Income (Loss) before Income Taxes

( i 678)

i 4,149

i 4,041

Income Tax Expense (Benefit)

( i 29)

i 900

i 981

Net Income (Loss)

( i 649)

i 3,249

i 3,060

Less: Net Income (Loss) Attributable to Noncontrolling Interests

( i 1)

i 11

i 13

Net Income (Loss) Attributable to Tyson

( i 648)

i 3,238

i 3,047

Net Income (Loss) Per Share Attributable to Tyson:

Class A Basic

( i 1.87)

i 9.18

i 8.57

Class B Basic

( i 1.68)

i 8.25

i 7.70

Diluted

( i 1.87)

i 8.92

i 8.34

See accompanying Notes to Consolidated Financial Statements.

TYSON FOODS, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

in millions

fiscal year ended

Net Income (Loss)

( i 649)

i 3,249

i 3,060

Other Comprehensive Income (Loss), Net of Taxes:

Derivatives accounted for as cash flow hedges

i 2

i 1

i 2

Investments

i 1

( i 7)

( i 1)

Currency translation

i 29

( i 162)

i 17

Postretirement benefits

i 5

i 43

( i 11)

Total Other Comprehensive Income (Loss), Net of Taxes

i 37

( i 125)

i 7

Comprehensive Income (Loss)

( i 612)

i 3,124

i 3,067

Less: Comprehensive Income (Loss) Attributable to Noncontrolling Interests

( i 1)

i 11

i 13

Comprehensive Income (Loss) Attributable to Tyson

( i 611)

i 3,113

i 3,054

See accompanying Notes to Consolidated Financial Statements.

TYSON FOODS, INC.

CONSOLIDATED BALANCE SHEETS


in millions, except share and per share data
	September 30, 2023		October 1, 2022
Assets
Current Assets:
Cash and cash equivalents	$	i 573	$	i 1,031
Accounts receivable, net	i 2,476		i 2,577
Inventories	i 5,328		i 5,514
Other current assets	i 345		i 508
Total Current Assets	i 8,722		i 9,630
Net Property, Plant and Equipment	i 9,634		i 8,685
Goodwill	i 9,878		i 10,513
Intangible Assets, net	i 6,098		i 6,252
Other Assets	i 1,919		i 1,741
Total Assets	$	i 36,251	$	i 36,821

Liabilities and Shareholders’ Equity
Current Liabilities:
Current debt	$	i 1,895	$	i 459
Accounts payable	i 2,594		i 2,483
Other current liabilities	i 2,010		i 2,371
Total Current Liabilities	i 6,499		i 5,313
Long-Term Debt	i 7,611		i 7,862
Deferred Income Taxes	i 2,308		i 2,458
Other Liabilities	i 1,578		i 1,377
Commitments and Contingencies (Note 20)
Shareholders’ Equity:
Common stock ($0.10 par value):
Class A-authorized 900 million shares, issued 378 million shares	i 38		i 38
Convertible Class B-authorized 900 million shares, issued 70 million shares	i 7		i 7
Capital in excess of par value	i 4,560		i 4,553
Retained earnings	i 18,760		i 20,084
Accumulated other comprehensive gain (loss)	( i 260)		( i 297)
Treasury stock, at cost – 92 million shares at September 30, 2023 and 88 million shares at October 1, 2022	( i 4,972)		( i 4,683)
Total Tyson Shareholders’ Equity	i 18,133		i 19,702
Noncontrolling Interests	i 122		i 109
Total Shareholders’ Equity	i 18,255		i 19,811
Total Liabilities and Shareholders’ Equity	$	i 36,251	$	i 36,821

See accompanying Notes to Consolidated Financial Statements.

TYSON FOODS, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

in millions

fiscal year ended

Amount

Class A Common Stock:

Balance at beginning and end of year

i i 378 /

i i 38 /

i i 378 /

i i 38 /

i i 378 /

i i 38 /

Class B Common Stock:

Balance at beginning and end of year

i i 70 /

i i 7 /

i i 70 /

i i 7 /

i i 70 /

i i 7 /

Capital in Excess of Par Value:

Balance at beginning of year

i 4,553

i 4,486

i 4,433

Stock-based compensation and other

i 7

i 67

i 53

Balance at end of year

i 4,560

i 4,553

i 4,486

Retained Earnings:

Balance at beginning of year

i 20,084

i 17,502

i 15,100

Net income (loss) attributable to Tyson

( i 648)

i 3,238

i 3,047

Dividends

( i 676)

( i 656)

( i 645)

Balance at end of year

i 18,760

i 20,084

i 17,502

Accumulated Other Comprehensive Income (Loss), Net of Tax:

Balance at beginning of year

( i 297)

( i 172)

( i 179)

Other comprehensive income (loss)

i 37

( i 125)

i 7

Balance at end of year

( i 260)

( i 297)

( i 172)

Treasury Stock:

Balance at beginning of year

i 88

( i 4,683)

i 83

( i 4,138)

i 83

( i 4,145)

Purchase of Class A common stock

i 6

( i 354)

i 8

( i 702)

i 1

( i 67)

Stock-based compensation

( i 2)

i 65

( i 3)

i 157

( i 1)

i 74

Balance at end of year

i 92

( i 4,972)

i 88

( i 4,683)

i 83

( i 4,138)

Total Shareholders’ Equity Attributable to Tyson

i 18,133

i 19,702

i 17,723

Equity Attributable to Noncontrolling Interests:

Balance at beginning of year

i 109

i 131

i 132

Net income (loss) attributable to noncontrolling interests

( i 1)

i 11

i 13

Distributions to noncontrolling interest

( i 14)

( i 11)

( i 8)

Business combinations

i 28

i —

Currency translation and other

i —

( i 22)

( i 6)

Total Equity Attributable to Noncontrolling Interests

i 122

i 109

i 131

Total Shareholders’ Equity

i 18,255

i 19,811

i 17,854

See accompanying Notes to Consolidated Financial Statements.

TYSON FOODS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

in millions

fiscal year ended

Cash Flows From Operating Activities:

Net income (loss)

( i 649)

i 3,249

i 3,060

Adjustments to reconcile net income to cash provided by operating activities:

Depreciation

i 1,100

i 945

i 934

Amortization

i 239

i 257

i 280

Deferred income taxes

( i 183)

i 264

( i 125)

Impairment of goodwill

i 781

i —

Gain on disposition of business

i —

( i 784)

Impairments and disposals of assets

i 101

i 34

i 60

Stock-based compensation expense

i 61

i 93

i 91

Other, net

i 115

( i 51)

( i 57)

(Increase) decrease in accounts receivable

i 136

( i 176)

( i 508)

(Increase) decrease in inventories

i 175

( i 1,195)

( i 567)

Increase (decrease) in accounts payable

i 47

i 302

i 351

Increase (decrease) in income taxes payable/receivable

i 108

( i 580)

i 421

Increase (decrease) in interest payable

i —

( i 13)

( i 5)

Net changes in other operating assets and liabilities

( i 279)

( i 442)

i 689

Cash Provided by Operating Activities

i 1,752

i 2,687

i 3,840

Cash Flows From Investing Activities:

Additions to property, plant and equipment

( i 1,939)

( i 1,887)

( i 1,209)

Purchases of marketable securities

( i 34)

( i 35)

( i 72)

Proceeds from sale of marketable securities

i 32

i 34

i 70

Proceeds from sale of businesses

i —

i 1,188

Acquisitions, net of cash acquired

( i 262)

i —

Acquisition of equity investments

( i 115)

( i 177)

( i 44)

Other, net

i 19

i 130

i 125

Cash Provided by (Used for) Investing Activities

( i 2,299)

( i 1,935)

i 58

Cash Flows From Financing Activities:

Proceeds from issuance of debt

i 1,130

i 103

i 585

Payments on debt

( i 603)

( i 1,191)

( i 2,632)

Proceeds from issuance of commercial paper

i 7,693

i —

Repayments of commercial paper

( i 7,103)

i —

Purchases of Tyson Class A common stock

( i 354)

( i 702)

( i 67)

Dividends

( i 670)

( i 653)

( i 636)

Stock options exercised

i 11

i 126

i 41

Other, net

( i 16)

( i 6)

( i 22)

Cash Provided by (Used for) Financing Activities

i 88

( i 2,323)

( i 2,731)

Effect of Exchange Rate Change on Cash

i 1

( i 35)

i 4

(Decrease) Increase in Cash and Cash Equivalents and Restricted Cash

( i 458)

( i 1,606)

i 1,171

Cash and Cash Equivalents and Restricted Cash at Beginning of Year

i 1,031

i 2,637

i 1,466

Cash and Cash Equivalents and Restricted Cash at End of Year

i 573

i 1,031

i 2,637

Less: Restricted Cash at End of Year

i —

i 130

Cash and Cash Equivalents at End of Year

i 573

i 1,031

i 2,507

See accompanying Notes to Consolidated Financial Statements.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

TYSON FOODS, INC.

NOTE 1: i BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

i Description of Business

Tyson Foods, Inc. (collectively, “Company,” “we,” “us” or “our”), is one of the world’s largest food companies and a recognized leader in protein. Founded in 1935 by John W. Tyson and grown under four generations of family leadership, the Company has a broad portfolio of products and brands including Tyson®, Jimmy Dean®, Hillshire Farm®, Ball Park®, Wright®, Aidells®, ibp® and State Fair®. We innovate continually to make protein more sustainable, tailor food for everywhere it’s available and raise the world’s expectations for how much good food can do.

i Consolidation

The consolidated financial statements include the accounts of all wholly-owned subsidiaries, as well as majority-owned subsidiaries over which we exercise control and, when applicable, entities for which we have a controlling financial interest or variable interest entities for which we are the primary beneficiary. All significant intercompany accounts and transactions have been eliminated in consolidation.

Fiscal Year

We utilize a 52- or 53-week accounting period ending on the Saturday closest to September 30. The Company’s accounting cycle resulted in a 52-week year for fiscal 2023, 2022 and 2021.

i Cash and Cash Equivalents

Cash equivalents consist of investments in short-term, highly liquid securities having original maturities of three months or less, which are made as part of our cash management activity. The carrying values of these assets approximate their fair values. We primarily utilize a cash management system with a series of separate accounts consisting of lockbox accounts for receiving cash, concentration accounts where funds are moved to, and several zero-balance disbursement accounts for funding payroll, accounts payable, livestock procurement, livestock grower payments, etc. As a result of our cash management system, checks issued, but not presented to the banks for payment, may result in negative book cash balances. These negative book cash balances are included in accounts payable and other current liabilities. Checks outstanding in excess of related book cash balances totaled approximately $ i 125 million and $ i 135 million at September 30, 2023, and October 1, 2022, respectively.

Accounts Receivable

We record accounts receivable at net realizable value. This value includes an appropriate allowance for estimated credit losses to reflect any loss anticipated on the accounts receivable balances and charged to the allowance for credit losses. We calculate this allowance based on our history of write-offs, future economic conditions, level of past due accounts, and relationships with and economic status of our customers. At September 30, 2023, and October 1, 2022, our allowance for credit losses was $ i 31 million and $ i 29 million, respectively. We generally do not have collateral for our receivables, but we do periodically evaluate the credit worthiness of our customers.

i Inventories

Processed products, livestock and supplies and other are valued at the lower of cost or net realizable value. Cost includes purchased raw materials, live purchase costs, livestock growout costs (primarily feed, livestock grower pay and catch and haul costs), labor and manufacturing and production overhead, which are related to the purchase and production of inventories. At September 30, 2023, the cost of inventories was determined by either the first-in, first-out (“FIFO”) method or the weighted-average method, which is consistent with the methods used at October 1, 2022. Inventories are presented net of lower of cost or net realizable value adjustments of $145 million and $60 million as of September 30, 2023 and October 1, 2022, respectively. i The following table reflects the major components of inventory as of September 30, 2023 and October 1, 2022 (in millions):



	2023		2022
Processed products	$	i 2,847	$	i 3,188
Livestock	i 1,594		i 1,454
Supplies and other	i 887		i 872
Total inventory	$	i 5,328	$	i 5,514

Property, Plant and Equipment

Property, plant and equipment are stated at cost and generally depreciated on a straight-line method over the estimated lives for buildings and leasehold improvements of i 10 to i 33 years, machinery and equipment of i 3 to i 12 years and land improvements and other of i 3 to i 20 years. Major repairs and maintenance costs that significantly extend the useful life of the related assets are capitalized. Normal repairs and maintenance costs are charged to operations. We review the carrying value of long-lived assets at each balance sheet date if indication of impairment exists. Recoverability is assessed using undiscounted cash flows based on historical results and current projections of earnings before interest, taxes, depreciation and amortization. We measure impairment as the excess of carrying value over the fair value of an asset group. The fair value of an asset group is generally measured using discounted cash flows including market participant assumptions of future operating results and discount rates.

/ i

Goodwill and Intangible Assets

Definite life intangibles are initially recorded at fair value and amortized over the estimated period of benefit. Brands and trademarks are generally amortized using the straight-line method over i 20 years or less. Customer relationships and supply arrangements are generally amortized over i 7 to i 30 years based on the pattern of revenue expected to be generated from the use of the asset. The gross cost and accumulated amortization of intangible assets are removed when the recorded amounts are fully amortized and the asset is no longer in use or the contract has expired. Amortization expense is generally recognized in selling, general, and administrative expense. We review the carrying value of definite life intangibles at each balance sheet date if indication of impairment exists. Recoverability is assessed using undiscounted cash flows based on historical results and current projections of earnings before interest, taxes, depreciation and amortization. We measure impairment as the excess of carrying value over the fair value of the definite life intangible asset group. We use various valuation techniques to estimate fair value, with the primary techniques being discounted cash flows, relief-from-royalty and multi-period excess earnings valuation approaches, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. Under these valuation approaches, we are required to make estimates and assumptions about sales growth, operating margins, royalty rates and discount rates based on budgets, business plans, economic projections, anticipated future cash flows and marketplace data.

Goodwill and indefinite life intangible assets are initially recorded at fair value and not amortized, but are reviewed for impairment at least annually or more frequently if impairment indicators arise. Our goodwill is allocated by reporting unit and is evaluated for impairment by first performing a qualitative assessment to determine whether a quantitative goodwill test is necessary. If it is determined, based on qualitative factors, the fair value of the reporting unit may more likely than not be less than carrying amount, or if significant changes to macro-economic factors related to the reporting unit have occurred that could materially impact fair value, a quantitative goodwill impairment test would be required. Additionally, we can elect to forgo the qualitative assessment and perform the quantitative test. The quantitative test is to identify if a potential impairment exists by comparing the fair value of a reporting unit with its carrying amount, including goodwill. If the carrying amount of the reporting unit exceeds the fair value, an impairment loss is recognized in an amount equal to that excess, not to exceed the carrying amount of goodwill.

We estimate the fair value of our reporting units considering the use of various valuation techniques, with the primary technique being an income approach (discounted cash flow method), with another technique being a market approach (guideline public company method), which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. We include assumptions about sales growth, operating margins, discount rates and valuations multiples which consider our budgets, business plans, economic projections and marketplace data, and are believed to reflect market participant views which would exist in an exit transaction. Assumptions are also made for varying perpetual growth rates for periods beyond the long-term business plan period. Generally, we utilize operating margin assumptions based on future expectations, operating margins historically realized in the reporting units' industries and industry marketplace valuation multiples.

Some of the inherent estimates and assumptions used in determining fair value of the reporting units are outside the control of management, including interest rates, cost of capital, tax rates, market EBITDA comparables and credit ratings. While we believe we have made reasonable estimates and assumptions to calculate the fair value of the reporting units, it is possible a material change could occur. If our actual results are not consistent with our estimates and assumptions used to calculate fair value, it could result in additional material impairments of our goodwill.

During the third quarter of fiscal 2023, we experienced lower than anticipated operating results and changing market fundamentals, as well as a drop in our market capitalization to below book value. Consequently, we performed an interim assessment of goodwill and recorded a $ i 448 million goodwill impairment charge of which $ i 210 million and $ i 238 million was recognized in our Chicken segment and International/Other, respectively. We performed our annual impairment assessment as of the first day of our fourth quarter in fiscal 2023, and it did not result in an additional goodwill impairment. However, during the fourth quarter of fiscal 2023, we experienced an increase in long-term treasury rates which caused a net 50 basis point increase in the discount rates used in estimating the fair value of the reporting units, and we determined it was necessary to perform a quantitative assessment for the Beef, Pork and two Chicken segment reporting units as of September 30, 2023. Based on this quantitative assessment, we determined that our Pork and two Chicken segment reporting units' estimated fair values exceeded their carrying values. For the Beef reporting unit, the increased discount rate resulted in a decrease in its estimated fair value to below its carrying value. Accordingly, we recognized a $ i 333 million goodwill impairment charge to partially impair its goodwill. During fiscal 2022 and 2021, we determined none of our reporting units’ fair values were below its carrying value.

We consider reporting units that have i 20% or less excess fair value over carrying amount to have a heightened risk of impairment. The following reporting units' were considered at heightened risk of impairment as of the date of the most recent estimated fair value determination: our Chicken segment reporting units, our Beef reporting unit and our Pork reporting unit with goodwill totaling $ i 3.1 billion, $ i 0.3 billion and $ i 0.4 billion, respectively, at September 30, 2023.

For our indefinite life intangible assets, a qualitative assessment can also be performed to determine whether the existence of events and circumstances indicates it is more likely than not an intangible asset is impaired. Similar to goodwill, we can also elect to forgo the qualitative test for indefinite life intangible assets and perform the quantitative test. Upon performing the quantitative test, if the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.

The fair value of our indefinite life intangible assets is calculated principally using multi-period excess earnings and relief-from-royalty valuation approaches, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy, and is believed to reflect market participant views which would exist in an exit transaction. Under these valuation approaches, we are required to make estimates and assumptions about sales growth, operating margins, royalty rates and discount rates based on budgets, business plans, economic projections, anticipated future cash flows and marketplace data. During fiscal 2023, 2022 and 2021, we determined the fair value of each of our indefinite life intangible assets exceeded its carrying value. We consider indefinite life intangible assets that have 20% or less excess fair value over carrying amount to have a heightened risk of impairment. All of our indefinite life intangible assets’ estimated fair value exceeded their carrying value by more than i 20% at the date of their most recent estimated fair value determination, which was in the annual assessment as of the beginning of the fourth quarter of fiscal 2023, other than two of our Prepared Foods brands with carrying values of $ i 0.5 billion and $ i 0.3 billion as of September 30, 2023.

Our reporting units with heightened risk of future impairments with $3.8 billion carrying value at September 30, 2023, as well as the brand with $0.5 billion carrying value, as described above, all have less than 10% of excess fair value above carrying value as of the date of the most recent estimated fair value determination. Consequently, their estimated fair values remain highly sensitive to future discount rate increases, changing macro-economic conditions and achievement of projected long-term operating margins. Discount rates increased by approximately 50 basis points from the date of our annual impairment assessment to September 30, 2023. Although the remaining reporting units and indefinite life intangible assets generally had more than 20% excess fair value over carrying amount as of the date of the most recent estimated fair value determination, they are also susceptible to impairments if any assumptions, estimates, or market factors significantly change in the future.

Leases

We determine if an agreement is or contains a lease at its inception by evaluating if an identified asset exists that we control for a period of time. When a lease exists, we classify it as a finance or operating lease and record a right-of-use (“ROU”) asset and a corresponding lease liability at lease commencement. We have elected to not record leases with a term of 12 months or less in our Consolidated Balance Sheets, and accordingly, lease expense for these short-term leases is recognized on a straight-line basis over the lease term. Finance lease assets are presented within Net Property, Plant and Equipment, and finance lease liabilities are presented within Current and Long-Term Debt in our Consolidated Balance Sheets. Finance lease disclosures are omitted as they are deemed immaterial. Operating ROU assets are presented within Other Assets, and operating lease liabilities are recorded within Other current liabilities and Other Liabilities in our Consolidated Balance Sheets. Lease assets are subject to review for impairment within the related long-lived asset group.

ROU assets are presented in our Consolidated Balance Sheets based on the present value of the corresponding liabilities and are adjusted for any prepayments, lease incentives received or initial direct costs incurred. The measurement of our ROU assets and liabilities includes all fixed payments and any variable payments based on an index or rate. Variable lease payments which do not depend on an index, or where rates are unknown, are excluded from lease payments in the measurement of the ROU asset and lease liability, and accordingly, are recognized as lease expense in the period the obligation for those payments is incurred. The present value of lease payments is based on our incremental borrowing rate according to the lease term and information available at the lease commencement date, as our lease arrangements generally do not provide an implicit interest rate. The incremental borrowing rate is derived using a hypothetically-collateralized borrowing cost, based on our revolving credit facility, plus a country risk factor, where applicable. We consider our credit rating and the current economic environment in determining the collateralized rate.

Our lease arrangements can include fixed or variable non-lease components, such as common area maintenance, taxes and labor. We account for each lease and any non-lease components associated with that lease as a single lease component for all asset classes, except production and livestock grower asset classes embedded in service and supply agreements, and other asset classes that include significant maintenance or service components. We account for lease and non-lease components of an agreement separately based on relative stand-alone prices either observable or estimated if observable prices are not readily available. For asset classes where an election was made not to separate lease and non-lease components, all costs associated with a lease contract are disclosed as lease costs. The accounting for some of the Company's leases may require significant judgment when determining whether a contract is or contains a lease, the lease term, and the likelihood of exercising renewal or termination options. Our leases can include options to extend or terminate use of the underlying assets. These options are included in the lease term used to determine ROU assets and corresponding liabilities when we are reasonably certain we will exercise the option. Additionally, certain leases can have residual value guarantees, which are included within our operating lease liabilities when considered probable. Our lease agreements do not include significant restrictions or covenants.

Recognition, measurement and presentation of expenses and cash flows arising from a lease will depend on classification as a finance or operating lease. Operating lease expense is recognized on a straight-line basis over the lease term, whereas the amortization of finance lease assets is recognized on a straight-line basis over the shorter of the estimated useful life of the underlying asset or the lease term. Operating lease expense and finance lease amortization are presented in Cost of Sales or Selling, General and Administrative in our Consolidated Statements of Income depending on the nature of the leased item. Interest expense on finance lease obligations is recorded over the lease term and is presented in Interest expense, based on the effective interest method. All operating lease cash payments and interest on finance leases are presented within Cash flows from operating activities and all finance lease principal payments are presented within cash flows from financing activities in our Consolidated Statements of Cash Flows.

Investments

We have investments in joint ventures and other entities. The equity method of accounting is used for entities in which we exercise significant influence but do not have a controlling interest or a variable interest in which we are the primary beneficiary. Under the equity method of accounting, the initial investment is recorded at cost and the investment is subsequently adjusted for its proportionate share of earnings or losses and dividends, including consideration of basis differences resulting from the difference between the initial carrying amount of the investment and the underlying equity in net assets, as applicable. Equity method investments totaled $ i 580 million and $ i 477 million at September 30, 2023 and October 1, 2022, respectively.

Investments not accounted for using the equity method do not have readily determinable fair values and do not qualify for the practical expedient to measure the investment using a net asset value per share. These investments are recorded using the measurement alternative in which our equity interests are recorded at cost, less impairments, adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer. At each reporting period, we assess if these investments continue to qualify for this measurement alternative. An impairment is recorded when there is evidence that the expected fair value of the investment has declined to below the recorded cost. Adjustments to the carrying value are recorded in Other, net in the Consolidated Statements of Income. Investments in joint ventures and other entities are reported in the Consolidated Balance Sheets in Other Assets.

We also have investments in marketable debt securities. We have determined all of our marketable debt securities are available-for-sale investments. These investments are reported at fair value based on quoted market prices as of the balance sheet date, with unrealized gains and losses, net of tax, recorded in other comprehensive income.

The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is recorded in interest income. The cost of securities sold is based on the specific identification method. Realized gains and losses on the sale of debt securities and declines in value due to credit-related factors are recorded on a net basis in other income. Interest and dividends on securities classified as available-for-sale are recorded in interest income.

/ i

Accrued Self-Insurance

We use a combination of insurance and self-insurance mechanisms in an effort to mitigate the potential liabilities for health and welfare, workers’ compensation, auto liability and general liability risks. Liabilities associated with our risks retained are estimated, in part, by considering claims experience, demographic factors, severity factors and other actuarial assumptions.

Other Current Liabilities

Other current liabilities as of September 30, 2023 and October 1, 2022, include (in millions):



	2023		2022
Accrued salaries, wages and benefits	$	i 672	$	i 995
Taxes payable	i 156		i 277
Accrued current legal contingencies	i 289		i 215
Other	i 893		i 884
Total other current liabilities	$	i 2,010	$	i 2,371

i Defined Benefit Plans

We recognize the funded status of defined pension and postretirement plans in the Consolidated Balance Sheets. The funded status is measured as the difference between the fair value of the plan assets and the benefit obligation. We measure our plan assets and liabilities at the end of our fiscal year. For a defined benefit pension plan, the benefit obligation is the projected benefit obligation; for any other defined benefit postretirement plan, such as a retiree health care plan, the benefit obligation is the accumulated postretirement benefit obligation. Any overfunded status is recognized as an asset and any underfunded status is recognized as a liability. Any transitional asset/liability, prior service cost or actuarial gain/loss that has not yet been recognized as a component of net periodic cost is recognized in accumulated other comprehensive income. Accumulated other comprehensive income will be adjusted as these amounts are subsequently recognized as a component of net periodic benefit costs in future periods.

i Derivative Financial Instruments

We purchase certain commodities, such as grains and livestock, during normal operations. As part of our commodity risk management activities, we use derivative financial instruments, primarily futures and options, to reduce our exposure to various market risks related to these purchases, as well as to changes in foreign currency exchange and interest rates. Contract terms of a financial instrument qualifying as a hedge instrument closely mirror those of the hedged item, providing a high degree of risk reduction and correlation. Contracts designated and highly effective at meeting risk reduction and correlation criteria are recorded using hedge accounting. If a derivative instrument is accounted for as a hedge, depending on the nature of the hedge, changes in the fair value of the instrument either will be offset against the change in fair value of the hedged assets, liabilities or firm commitments through earnings, or be recognized in Other Comprehensive Income (Loss) until the hedged item is recognized in earnings. The ineffective portion of an instrument’s change in fair value is recognized immediately. Instruments we hold as part of our risk management activities that do not meet the criteria for hedge accounting are marked to fair value with unrealized gains or losses reported currently in earnings. Changes in market value of derivatives used in our risk management activities relating to inputs of forward sales contracts are recorded in Cost of Sales. Changes in market value of derivatives used in our risk management activities surrounding inventories on hand or anticipated purchases of inventories are recorded in Cost of Sales. Changes in market value of derivatives used in our risk management activities related to interest rates are recorded in Interest expense. Changes in the market value of derivatives used in our risk management activities related to foreign exchange contracts are recorded in Other, net. We generally do not hedge anticipated transactions beyond 18 months.

Litigation Accruals

There are a variety of legal proceedings pending or threatened against us. Accruals are recorded when it is probable a liability has been incurred and the amount of the liability can be reasonably estimated based on current law, progress of each case, opinions and views of legal counsel and other advisers, our experience in similar matters and intended response to the litigation. These amounts, which are not discounted and are exclusive of claims against third parties, are adjusted periodically as assessment efforts progress or additional information becomes available. We expense amounts for administering or litigating claims as incurred. Accruals for legal proceedings are included in Other current liabilities in the Consolidated Balance Sheets.

Supplier Financing Programs

We have supplier financing programs with financial institutions, in which we agree to pay the financial institution the stated amount of confirmed invoices on the invoice due date for participating suppliers. Participation in these programs is optional and solely up to the supplier, who negotiates the terms of the arrangement directly with the financial institution and may allow early payment. Supplier participation in these programs has no bearing on the Company's amounts due. The payment terms that we have with participating suppliers under these programs are generally up to 120 days. We do not have an economic interest in a supplier's participation in the program or a direct financial relationship with the financial institution funding the program. We are responsible for ensuring that participating financial institutions are paid according to the terms negotiated with the supplier. The outstanding payment obligations due to the financial institutions as of the end of a period are included in accounts payable in the Consolidated Balance Sheets. The activity related to these programs is reflected within the operating activities section of the Consolidated Statements of Cash Flows. Supplier financing program disclosures are omitted as they are deemed immaterial.

Revenue Recognition

We recognize revenue mainly through retail, foodservice, international, industrial and other distribution channels. Our revenues primarily result from contracts with customers and are generally short term in nature with the delivery of product as the single performance obligation. We recognize revenue for the sale of the product at the point in time when our performance obligation has been satisfied and control of the product has transferred to our customer, which generally occurs upon shipment or delivery to a customer based on terms of the sale. We elected to account for shipping and handling activities that occur after the customer has obtained control of the product as a fulfillment cost rather than an additional promised service. Our contracts are generally less than one year, and therefore we recognize costs paid to third party brokers to obtain contracts as expenses. Additionally, items that are not material in the context of the contract are recognized as expense. Any taxes collected on behalf of government authorities are excluded from net revenues.

Revenue is measured by the transaction price, which is defined as the amount of consideration we expect to receive in exchange for providing goods to customers. The transaction price is adjusted for estimates of known or expected variable consideration, which includes consumer incentives, trade promotions, and allowances, such as coupons, discounts, rebates, volume-based incentives, cooperative advertising, and other programs. Variable consideration related to these programs is recorded as a reduction to revenue based on amounts we expect to pay. We base these estimates on current performance, historical utilization, and projected redemption rates of each program. We review and update these estimates regularly until the incentives or product returns are realized and the impact of any adjustments are recognized in the period the adjustments are identified. In many cases, key sales terms such as pricing and quantities ordered are established on a regular basis such that most customer arrangements and related incentives have a duration of less than one year. Amounts billed and due from customers are short term in nature and are classified as receivables since payments are unconditional and only the passage of time is required before payments are due. Additionally, we do not grant payment financing terms greater than one year. Freight expense associated with products shipped to customers is recognized in cost of sales.

i Advertising Expenses

Advertising expense is charged to operations in the period incurred and is recorded as selling, general and administrative expense. Advertising expense totaled $ i 339 million, $ i 283 million, and $ i 246 million in fiscal 2023, 2022 and 2021, respectively.

Research and Development

Research and development costs are expensed as incurred. Research and development costs totaled $ i 114 million, $ i 108 million, $ i 114 million in fiscal 2023, 2022 and 2021, respectively.

/ i

Business Combinations

We account for acquired businesses using the acquisition method of accounting, which requires that once control of a business is obtained, 100% of the assets acquired and liabilities assumed, including amounts attributable to noncontrolling interests, be recorded at the date of acquisition at their respective fair values. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses including transaction and integration costs are expensed as incurred.

We use various models to determine the value of assets acquired such as net realizable value to value inventory, cost method and market approach to value property, relief-from-royalty and multi-period excess earnings to value intangibles, and discounted cash flow to value goodwill. We make estimates and assumptions about projected future cash flows including sales growth, operating margins, attrition rates, and discount rates based on historical results, business plans, expected synergies, perceived risk, and marketplace data considering the perspective of marketplace participants. Determining the useful life of an intangible asset also requires judgment as different types of intangible assets will have different useful lives and certain assets may be considered to have indefinite useful lives.

Government Assistance Programs

We periodically receive government assistance typically in the form of cash grants or refundable tax credits (collectively “Grant” or “Grants”). The Grants generally specify conditions that must be met in order for the Grants to be earned, such as employment, employee retention targets, and construction or acquisition of property and equipment and are often time-bound. If conditions are not satisfied or if the duration period for the arrangement is not met, the Grants may be subject to reduction, repayment, or termination.

During fiscal years 2023, 2022, and 2021, we received amounts related to Grants that were not material to the financial statements; however, this conclusion can change based on additional grants received in the future. To the extent amounts have been received by the Company in advance of completion of the conditions, they have been recognized in other current liabilities or other liabilities in the Consolidated Balance Sheets, as appropriate.

Use of Estimates

The consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. During fiscal 2023, we revised estimates and recorded adjustments of approximately $30 million primarily to reduce certain employee compensation accruals recorded as of October 1, 2022.

Recently Issued Accounting Pronouncements

In March 2023, the FASB issued authoritative guidance intended to address issues related to arrangements between entities under common control such as terms and conditions an entity should consider for determining whether a lease exists and the classification and accounting for that lease as well as accounting for leasehold improvements associated with leases between entities under common control. The guidance is effective for annual reporting periods and interim periods within those annual reporting periods beginning after December 15, 2023, our fiscal 2025 and can be applied using either the prospective or retrospective approach. We are currently evaluating the impact this guidance will have on our consolidated financial statements.

In March 2020, the FASB issued guidance providing optional expedients and exceptions to account for the effects of reference rate reform to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued. The optional guidance, which became effective on March 12, 2020 and was set to end on December 31, 2022, was extended by new guidance issued by the FASB on December 21, 2022 to apply through December 31, 2024. The temporary accounting relief provided in the optional guidance has not impacted our consolidated financial statements. The Company has various contracts that reference LIBOR and is assessing how this standard may be applied to specific contract modifications through December 31, 2024.

NOTE 2: i CHANGES IN ACCOUNTING PRINCIPLES

In September 2022, the FASB issued guidance that requires additional disclosures for supplier finance programs to allow users to better understand the nature, activity and potential magnitude of the programs. The guidance, except for a requirement for rollforward information, is effective for annual reporting periods and interim periods within those annual reporting periods beginning after December 15, 2022, our fiscal 2024. Disclosure of rollforward information is effective for fiscal years after December 15, 2023, our fiscal 2025. Early adoption is permitted and the retrospective transition method should be applied for all amendments except rollforward information, which should be applied prospectively. We elected to early adopt the initial disclosure requirement for the fiscal year ended September 30, 2023, and it did not have a material impact on our consolidated financial statements.

In November 2021, the FASB issued authoritative guidance intended to provide consistent and transparent disclosures around government assistance by requiring disclosures of the type of government assistance, our method of accounting for the government assistance and the effect on our financial statements. This guidance is effective for annual reporting periods beginning after December 15, 2021, our fiscal 2023 and can be applied using either the prospective or retrospective approach. We adopted this guidance for the fiscal year ended September 30, 2023, and it did not have a material impact on our consolidated financial statements as amounts received from government assistance programs were not material.

NOTE 3: i ACQUISITIONS AND DISPOSITIONS

Acquisitions

In the third quarter of fiscal 2023, we acquired Williams Sausage Company for $ i 223 million, net of cash acquired, subject to certain adjustments, as part of our growth strategy to increase our capacity and product portfolio. Its results, subsequent to the acquisition closing, are included in the Prepared Foods segment and through September 30, 2023, were insignificant to our Consolidated Statements of Income. Certain estimated values for the acquisition, including goodwill, intangible assets, property, plant and equipment, other liabilities, and deferred taxes are not yet finalized and are subject to adjustment as additional information becomes available and more detailed analyses are completed. The preliminary purchase price allocation includes $ i 2 million of net working capital, including $ i 3 million of cash acquired, $ i 67 million of Property, Plant and Equipment, $ i 120 million of Goodwill, $ i 65 million of Intangible Assets, and $ i 28 million of Deferred Income Taxes. Intangible Assets include brands and trademarks and customer relationships which will be amortized over a life of i 20 and i 12 years, respectively. $ i 46 million of the goodwill is deductible for U.S. income tax purposes. The acquisition of Williams Sausage Company was accounted for using the acquisition method of accounting.

In the first quarter of fiscal 2023, we completed the acquisition of a i 60% equity stake in Supreme Foods Processing Company ("SFPC"), a producer and distributor of value-added and cooked chicken and beef products, and a i 15% equity stake in Agricultural Development Company ("ADC"), a fully integrated poultry company, for a total purchase price of $ i 75 million, net of cash acquired. Both SFPC and ADC were subsidiaries of Tanmiah Food Company. The results of SFPC, subsequent to the acquisition closing, are included in International/Other for segment presentation and through September 30, 2023 were insignificant to our Consolidated Statements of Income. We are accounting for the investment in ADC under the equity method.

Acquisition of equity method investments in fiscal 2023, which totaled $115 million, primarily included ADC and the purchase of a minority interest in a global insect-based ingredients company as well as deferred payments related to a prior year investment.

In the fourth quarter of fiscal 2022, we acquired a i 35% minority interest in a South American-based fully integrated poultry company for approximately $ i 100 million. We are accounting for the investment under the equity method.

In the third quarter of fiscal 2021, we acquired a i 49% minority interest in a Malaysian producer of feed and poultry products for $ i 44 million in addition to future contingent payments of up to approximately $ i 65 million of which $ i 27 million was recognized in fiscal 2023. We are accounting for the investment under the equity method.

Dispositions

We completed the sale of our pet treats business, which was included in our Prepared Foods segment, in the fourth quarter of fiscal 2021 for $ i 1.2 billion, subject to certain adjustments. As a result of the sale, we recorded a pretax gain of $784 million, or post tax gain of $ i 510 million, which was reflected in Cost of Sales in our Consolidated Statement of Income for our fiscal 2021. The business had a net carrying value of $ i 411 million which included $ i 44 million of working capital consisting of inventory, accounts receivable and accounts payable, $ i 17 million of property, plant and equipment and $ i 350 million of goodwill. The goodwill was not deductible for tax purposes. The Company concluded the business was not a significant disposal and did not represent a strategic shift, and therefore was not classified as a discontinued operation for any of the periods presented.

NOTE 4: i PROPERTY, PLANT AND EQUIPMENT

i The following table reflects major categories of property, plant and equipment and accumulated depreciation as of September 30, 2023 and October 1, 2022 (in millions):



	2023		2022
Land	$	i 219	$	i 214
Building and leasehold improvements	i 6,460		i 5,742
Machinery and equipment	i 10,680		i 9,960
Land improvements and other	i 559		i 516
Buildings and equipment under construction	i 1,782		i 1,461
	i 19,700		i 17,893
Less accumulated depreciation	i 10,066		i 9,208
Net property, plant and equipment	$	i 9,634	$	i 8,685

NOTE 5: i GOODWILL AND INTANGIBLE ASSETS

The following table reflects goodwill activity for fiscal years 2023 and 2022 (in millions):

Beef

Pork

Chicken

Prepared
Foods

International/Other

Consolidated

Balance at October 2, 2021 (a)

i 676

i 423

i 3,274

i 5,784

i 392

i 10,549

Fiscal 2022 Activity:

Currency translation

—

( i 1)

—

( i 35)

( i 36)

Balance at October 1, 2022 (a)

i 676

i 423

i 3,273

i 5,784

i 357

i 10,513

Fiscal 2023 Activity:

Acquisitions

—

i 118

i 19

i 137

Measurement period adjustments

—

i 2

—

i 2

Impairment losses

( i 333)

—

( i 210)

—

( i 238)

( i 781)

Currency translation

—

i 1

—

i 6

i 7

Balance at September 30, 2023 (a)

i 343

i 423

i 3,064

i 5,904

i 144

i 9,878

(a) Included in goodwill as of September 30, 2023 are accumulated impairment losses of $ i 893 million in Beef, $ i 210 million in Chicken and $ i 295 million in International/Other. Included in goodwill as of October 1, 2022 and October 2, 2021 are accumulated impairment losses of $ i i 560 / million in Beef and $ i i 57 / million in International/Other.

i The following table reflects intangible assets by type as of September 30, 2023 and October 1, 2022 (in millions):



	2023		2022
Amortizable intangible assets:
Brands and trademarks	$	i 1,007	$	i 951
Customer relationships	i 2,389		i 2,371
Supply arrangements	i 310		i 310
Patents, intellectual property and other	i 46		i 45
Land use rights	i 9		i 9
Total gross amortizable intangible assets	$	i 3,761	$	i 3,686
Less accumulated amortization	i 1,741		i 1,512
Total net amortizable intangible assets	$	i 2,020	$	i 2,174
Brands and trademarks not subject to amortization	i 4,078		i 4,078
Total intangible assets	$	i 6,098	$	i 6,252

Amortization expense of $ i 229 million, $ i 246 million and $ i 261 million was recognized during fiscal 2023, 2022 and 2021, respectively. We estimate amortization expense on intangible assets for the next five fiscal years subsequent to September 30, 2023, will be: 2024 - $ i 226 million; 2025 - $ i 217 million; 2026 - $ i 211 million; 2027 - $ i 199 million; 2028 - $ i 191 million.

NOTE 6: i LEASES

We lease certain equipment, buildings and land related to transportation, distribution, storage, production, livestock grower assets and office activities. These lease arrangements can be structured as a standard lease agreement or embedded in a service or supply agreement and are primarily classified as operating leases. For further description of our lease accounting policy, refer to Note 1: Business and Summary of Significant Accounting Policies. i Operating lease ROU assets and liabilities presented in our Consolidated Balance Sheets were as follows as of September 30, 2023 and October 1, 2022 (in millions):



	2023		2022
Other Assets	$	i 544	$	i 507
Other current liabilities	i 153		i 145
Other Liabilities	i 376		i 350

The components of lease costs for fiscal years 2023, 2022 and 2021 were as follows (in millions):

2023

2022

2021

Operating lease cost (a)

i 181

i 175

i 183

Variable lease cost (b)

i 531

i 508

i 473

Short-term lease cost

i 39

i 30

i 33

Total

i 751

i 713

i 689

(a) Sublease income is immaterial and not deducted from operating lease cost.

(b) Variable lease costs are determined based on volume of output received, flocks placed or other performance metrics.

Other operating lease information includes the following for fiscal years 2023, 2022 and 2021:


	2023			2022			2021
Operating cash outflows from operating leases (in millions)	$	i 191		$	i 194		$	i 204
ROU assets obtained in exchange for new operating lease liabilities (in millions)	$	i 288		$	i 159		$	i 197
Weighted-average remaining lease term	i 5 years			i 5 years
Weighted-average discount rate	i 4		%	i 3		%

At September 30, 2023, future maturities of operating leases were as follows (in millions):



Operating Lease Commitments
2024	$	i 171
2025	i 132
2026	i 89
2027	i 57
2028	i 43
2029 and beyond	i 99
Total undiscounted operating lease payments	$	i 591
Less: Imputed interest	i 62
Present value of total operating lease liabilities	$	i 529

At September 30, 2023, our leases that had not yet commenced were i not significant.

NOTE 7: i RESTRUCTURING AND RELATED CHARGES

2022 Program

The Company approved a restructuring program in fiscal 2022 (the “2022 Program”), to improve business performance, increase collaboration, enhance team member agility, enable faster decision-making and reduce redundancies. In conjunction with the 2022 Program, the Company relocated all its corporate team members from its former Chicago, Downers Grove and Dakota Dunes area corporate locations to its world headquarters in Springdale, Arkansas. In fiscal 2023, the Company approved an extension to the program to remove additional redundancies in corporate overhead. Additionally, during fiscal 2023, we revised the total 2022 Program anticipated expenses down $ i 69 million due to revised estimates related to relocation, lease terminations, and professional and other fees, based on actual experience, which were partially offset by increased severance costs associated with the program extension. We anticipate the 2022 Program and associated expenses will be complete in our fiscal 2025. i The following table reflects the total pretax anticipated expenses associated with the 2022 Program (in millions):

Beef

Pork

Chicken

Prepared Foods

International/Other

Total

Severance costs

i 24

i 7

i 20

i 52

i 19

i 122

Relocation and related costs

i 21

i 7

i 4

i 21

i 1

i 54

Accelerated depreciation

i 5

i 2

i —

i 12

i —

i 19

Contract and lease terminations

i —

i 21

i —

i 21

Professional and other fees

i 2

i 1

i —

i 3

i 2

i 8

Total 2022 Program

i 52

i 17

i 24

i 109

i 22

i 224

Restructuring costs include severance expenses and related charges directly associated with the 2022 Program such as relocation, contract and lease terminations, professional fees and accelerated depreciation resulting from the closure of facilities. We anticipate that $ i 50 million and $ i 174 million of the total pretax anticipated expense will be recorded in Cost of Sales and Selling, General and Administrative, respectively, in our Consolidated Statements of Income. Included in the table above are $ i 202 million of charges that have resulted or will result in cash outflows and $ i 22 million in non-cash charges.

The following table reflects the pretax impact of the 2022 Program’s restructuring and related charges during fiscal 2023 by reportable segment (in millions):

Beef

Pork

Chicken

Prepared Foods

International/Other

Total

Severance costs

i 8

i 2

i 14

i 16

i 15

i 55

Relocation and related costs

i 18

i 6

i 2

i 16

i —

i 42

Accelerated depreciation

i 5

i 2

i —

i 12

i —

i 19

Contract and lease terminations

i —

i 2

i —

i 2

Professional and other fees

i 2

i 1

i —

i 3

i —

i 6

Total

i 33

i 11

i 16

i 49

i 15

i 124

During fiscal 2023, we recorded restructuring and related charges associated with the 2022 Program of $29 million and $95 million in Cost of Sales and Selling, General and Administrative, respectively, in our Consolidated Statements of Income. Included in the above results are $ i 108 million of charges that have resulted or will result in cash outflows and $ i 16 million in non-cash charges.

The following table reflects the pretax impact of the 2022 Program’s restructuring and related charges during fiscal 2022 by reportable segment (in millions):

Beef

Pork

Chicken

Prepared Foods

International/Other

Total

Severance costs

i 16

i 5

i 6

i 36

i 3

i 66

Relocation and related costs

i —

Accelerated depreciation

i —

Contract and lease terminations

i —

Professional and other fees

i —

Total

i 16

i 5

i 6

i 36

i 3

i 66

During fiscal 2022, we recorded restructuring and related charges associated with the 2022 Program of $18 million and $48 million in Cost of Sales and Selling, General and Administrative, respectively, in our Consolidated Statements of Income. Included in the above results are $ i 66 million of charges that have resulted or will result in cash outflows and i no non-cash charges.

The following table reflects the pretax 2022 Program charges to date by reportable segment (in millions):

Beef

Pork

Chicken

Prepared Foods

International/Other

Total

Severance costs

i 24

i 7

i 20

i 52

i 18

i 121

Relocation and related costs

i 18

i 6

i 2

i 16

i —

i 42

Accelerated depreciation

i 5

i 2

i —

i 12

i —

i 19

Contract and lease terminations

i —

i 2

i —

i 2

Professional and other fees

i 2

i 1

i —

i 3

i —

i 6

Total 2022 Program charges to date

i 49

i 16

i 22

i 85

i 18

i 190

As of the fourth quarter of fiscal 2023, we recorded restructuring and related charges to date of $ i 47 million and $ i 143 million in Cost of Sales and Selling, General and Administrative, respectively, in our Consolidated Statements of Income. Included in the above results are $ i 174 million of charges to date that have resulted or will result in cash outflows and $ i 16 million in non-cash charges to date.

The following table reflects our liability related to the 2022 Program, which was recognized in other current liabilities in our Consolidated Balance sheet as of September 30, 2023 (in millions):

Balance at October 1, 2022

Restructuring Expense

Payments

Changes in Estimates

Balance at
September 30, 2023

Severance costs

i 66

i 68

( i 63)

( i 13)

i 58

Relocation and related costs

i —

i 42

( i 37)

i —

i 5

Contract and lease termination

i —

i 5

( i 5)

—

Professional and other fees

i —

i 6

( i 4)

i —

i 2

Total

i 66

i 121

( i 109)

( i 13)

i 65

As the Company continues to evaluate its business strategies and long-term growth targets, additional restructuring activities may occur.

Plant Closures

During fiscal 2023, as part of a strategic review of assets, the Company approved the closure of six Chicken segment processing facilities located in Glen Allen, Virginia; Van Buren, Arkansas; Corydon, Indiana; Dexter, Missouri; Noel, Missouri; and North Little Rock, Arkansas, to optimize asset utilization. We shifted production to other facilities and ceased operations at our Glen Allen and Van Buren facilities during fiscal 2023 and expect to shift production and cease operations at the remaining locations during the first half of fiscal 2024. As a result of the closures, we recorded $ i 322 million of charges in fiscal 2023, primarily related to grower contract terminations, impairments, accelerated depreciation, severance, retention and related costs. Additionally, during fiscal 2023, we recorded an impairment charge of $ i 17 million related to the discontinuation of a product line in the Prepared Foods segment. The charges are reflected in the Consolidated Statements of Income in Cost of Sales and included $ i 201 million of charges that have resulted or will result in cash outflows and $ i 138 million in non-cash charges. Our plant closure liability was $ i 165 million as of September 30, 2023, and we had no plant closure liability as of October 1, 2022. We made cash payments of $ i 36 million in fiscal 2023 related to the plant closures. We continue to strategically evaluate optimization of such items as network capacity, manufacturing efficiencies and business technology. If we have a significant change in strategies, outlook, or a manner in which we plan to use these assets, we may be exposed to future impairments.

NOTE 8: i DEBT

i The following table reflects major components of debt as of September 30, 2023 and October 1, 2022 (in millions):



	2023		2022
Revolving credit facility	$	i —	$	i —
Commercial Paper	i 592		i —
Senior notes:
3.90% Notes due September 2023	i —		i 400
3.95% Notes due August 2024	i 1,250		i 1,250
4.00% Notes due March 2026 (“2026 Notes”)	i 800		i 800
3.55% Notes due June 2027	i 1,350		i 1,350
7.00% Notes due January 2028	i 18		i 18
4.35% Notes due March 2029 (“2029 Notes”)	i 1,000		i 1,000
6.13% Notes due November 2032	i 158		i 160
4.88% Notes due August 2034	i 500		i 500
5.15% Notes due August 2044	i 500		i 500
4.55% Notes due June 2047	i 750		i 750
5.10% Notes due September 2048 (“2048 Notes”)	i 1,500		i 1,500
Discount on senior notes	( i 36)		( i 39)
Term loans:
Term loan facility due May 2026 (6.55% at September 30, 2023)	i 1,000		i —
Term loan facility due May 2028	i —		i —
Other	i 164		i 175
Unamortized debt issuance costs	( i 40)		( i 43)
Total debt	i 9,506		i 8,321
Less current debt	i 1,895		i 459
Total long-term debt	$	i 7,611	$	i 7,862

Annual maturities of debt for the five fiscal years subsequent to September 30, 2023 are: 2024 - $ i 1,899 million; 2025 - $ i 26 million; 2026 - $ i 1,818 million; 2027 - $ i 1,364 million; 2028 - $ i 23 million.

Revolving Credit Facility and Letters of Credit

We have a $ i 2.25 billion revolving credit facility that supports short-term funding needs and serves as a backstop to our commercial paper program. The facility will mature and the commitments thereunder will terminate in September 2026 with options for two one-year extensions. At September 30, 2023, amounts available for borrowing under this facility totaled $ i 2.25 billion before deducting amounts to backstop our commercial paper program. At September 30, 2023 we had i no borrowings and i no outstanding letters of credit issued under this facility. At September 30, 2023 we had $ i 96 million of bilateral letters of credit issued separately from the revolving credit facility, none of which were drawn upon. Our letters of credit are issued primarily in support of workers’ compensation insurance programs and other legal obligations. In the future, if any of our subsidiaries shall guarantee any of our material indebtedness, such subsidiary shall be required to guarantee the indebtedness, obligations and liabilities under this facility. In November 2022, we entered into an amendment to change the reference rate from the London interbank offered rate (commonly referred to as LIBOR) to a rate based on the secured overnight financing rate (commonly referred to as SOFR).

Commercial Paper Program

We have a commercial paper program under which we may issue unsecured short-term promissory notes up to an aggregate maximum principal amount of $ i 1.5 billion. As of September 30, 2023, we had $ i 592 million of commercial paper outstanding at a weighted average interest rate of i 5.48% with maturities of less than i 20 days. Our ability to access commercial paper in the future may be limited or its costs increased.

Term Loan Facilities

In the third quarter of fiscal 2023, we executed two new term loan facilities totaling $ i 1.75 billion to refinance our short-term promissory notes ("commercial paper program") and for general corporate purposes. The first term loan facility totaling $ i 1.0 billion matures on May 3, 2026 and we borrowed the full $ i 1.0 billion available under this loan facility. The second term loan facility totaling $ i 750 million matures on May 3, 2028 and at September 30, 2023, we had no outstanding borrowings under this facility. In November 2023, we borrowed the full $ i 750 million available under the second term loan facility to refinance the outstanding commercial paper and for general corporate purposes. Both term loans may be prepaid under certain conditions. The interest rate on both term loan facilities will be equal to SOFR plus a predetermined borrowing spread determined by our credit rating. Additionally, the term loan facilities contain covenants that are similar to those contained in the revolving credit facility.

Debt Covenants

Our revolving credit facility and term loan facilities contain affirmative and negative covenants that, among other things, may limit or restrict our ability to: create liens and encumbrances; incur debt; merge, dissolve, liquidate or consolidate; make acquisitions and investments; dispose of or transfer assets; change the nature of our business; engage in certain transactions with affiliates; and enter into hedging transactions, in each case, subject to certain qualifications and exceptions. In addition, we are required to maintain a minimum interest expense coverage ratio.

We were in compliance with all debt covenants at September 30, 2023.

NOTE 9: i EQUITY

Capital Stock

We have i two classes of capital stock, Class A Common stock, $ i 0.10 par value (“Class A stock”) and Class B Common Stock, $ i 0.10 par value (“Class B stock”). Holders of Class B stock may convert such stock into Class A stock on a share-for-share basis. Holders of Class B stock are entitled to i 10 votes per share, while holders of Class A stock are entitled to i one vote per share on matters submitted to shareholders for approval. As of September 30, 2023, TLP owned i 99.985% of the outstanding shares of Class B stock and the TLP and members of the Tyson family owned, in the aggregate, i 2.44% of the outstanding shares of Class A stock, giving them, collectively, control of approximately i 71.74% of the total voting power of the outstanding voting stock.

The Class B stock is considered a participating security requiring the use of the two-class method for the computation of basic earnings per share. The two-class computation method for each period reflects the cash dividends paid for each class of stock, plus the amount of allocated undistributed earnings (losses) computed using the participation percentage, which reflects the dividend rights of each class of stock. Basic earnings per share were computed using the two-class method for all periods presented. The shares of Class B stock are considered to be participating convertible securities since the shares of Class B stock are convertible on a share-for-share basis into shares of Class A stock. Diluted earnings per share, if dilutive, were computed assuming the conversion of the Class B shares into Class A shares as of the beginning of each period.

Dividends

Cash dividends cannot be paid to holders of Class B stock unless they are simultaneously paid to holders of Class A stock. The per share amount of the cash dividend paid to holders of Class B stock cannot exceed i 90% of the cash dividend simultaneously paid to holders of Class A stock. We pay quarterly cash dividends to Class A and Class B shareholders. We paid Class A dividends per share of $ i 1.92, $ i 1.84, and $ i 1.78 in fiscal 2023, 2022, and 2021, respectively. We paid Class B dividends per share of $ i 1.73, $ i 1.66, and $ i 1.60 in fiscal 2023, 2022, and 2021, respectively. Effective November 10, 2023, the Board of Directors increased the quarterly dividend previously declared on August 10, 2023, to $ i 0.49 per share on our Class A stock and $ i 0.441 per share on our Class B stock. The increased quarterly dividend is payable on December 15, 2023, to shareholders of record at the close of business on December 1, 2023. We had dividends payable of $ i 167 million and $ i 162 million at September 30, 2023 and October 1, 2022, respectively.

Share Repurchases

As of September 30, 2023, i 7.3 million shares remained available for repurchase under the Company’s share repurchase program. The program has no fixed or scheduled termination date and the timing and extent to which we repurchase shares will depend upon, among other things, our working capital needs, markets, industry conditions, liquidity targets, limitations under our debt obligations and regulatory requirements. In addition to the share repurchase program, we purchase shares on the open market to fund certain obligations under our equity compensation plans.

i A summary of cumulative share repurchases of our Class A stock for fiscal years 2023, 2022 and 2021 is as follows (in millions):

Dollars

Shares repurchased:

Under share repurchase program

i 4.7

i 300

i 6.9

i 587

i —

To fund certain obligations under equity compensation plans

i 0.9

i 54

i 1.3

i 115

i 0.9

i 67

Total share repurchases

i 5.6

i 354

i 8.2

i 702

i 0.9

i 67

NOTE 10: i INCOME TAXES

i Detail of the provision for income taxes from continuing operations consists of the following for fiscal years 2023, 2022 and 2021 (in millions):

2023

2022

2021

Federal

( i 39)

i 764

i 791

State

( i 38)

i 94

i 163

Foreign

i 48

i 42

i 27

( i 29)

i 900

i 981

Current

i 154

i 636

i 1,106

Deferred

( i 183)

i 264

( i 125)

( i 29)

i 900

i 981

i The reasons for the difference between the statutory federal income tax rate and our effective income tax rate from continuing operations are as follows for fiscal years 2023, 2022 and 2021:

2023

2022

2021

Federal income tax rate

i 21.0

State income taxes

( i 0.7)

i 2.9

i 3.3

Foreign-derived intangible income deduction

i —

( i 1.0)

( i 1.1)

Deferred income tax remeasurement

i 3.8

( i 0.9)

i —

General business credits

i 3.4

( i 0.5)

Goodwill

( i 24.2)

i —

i 1.8

Other

i 1.0

i 0.2

( i 0.2)

i 4.3

i 21.7

i 24.3

During fiscal 2023, state tax benefit, net of federal impact, was $ i 21 million, which includes $ i 26 million benefit related to the remeasurement of deferred income taxes, primarily due to legislation decreasing state tax rates enacted in fiscal 2023. Non-deductible goodwill impairments unfavorably impacted the effective tax rate by i 24.2%. The tax benefit from income tax credits was $ i 23 million.

During fiscal 2022, state tax expense, net of federal benefit, was $ i 83 million, which includes $ i 36 million benefit related to the remeasurement of deferred income taxes, primarily due to legislation decreasing state tax rates enacted in fiscal 2022. The tax benefit from foreign-derived intangible income deduction was $ i 42 million.

During fiscal 2021, state tax expense, net of federal benefit, was $ i 135 million, and the tax benefit from foreign-derived intangible income deduction was $ i 44 million. Non-deductible goodwill associated with the sale of our pet treats business increased the effective tax rate by i 1.8%.

Approximately ($ i 643) million, $ i 4,025 million and $ i 3,963 million of income (loss) from continuing operations before income taxes for fiscal 2023, 2022 and 2021, respectively, were from our operations based in the United States.

We recognize deferred income taxes for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

i The tax effects of major items recorded as deferred tax assets and liabilities as of September 30, 2023 and October 1, 2022, are as follows (in millions):

2023

2022

Assets

Liabilities

Assets

Liabilities

Property, plant and equipment

i —

i 1,030

i —

i 1,091

Intangible assets

i —

i 1,495

i —

i 1,515

ROU assets

i —

i 150

i —

i 144

Accrued expenses

i 400

i —

i 410

i —

Lease liabilities

i 135

i —

i 126

i —

Net operating loss and other carryforwards

i 192

—

i 198

—

Other

i 193

i 346

i 87

i 326

i 920

i 3,021

i 821

i 3,076

Valuation allowance

( i 199)

( i 195)

Net deferred tax liability

i 2,300

i 2,450

At September 30, 2023, our gross state net operating loss carryforwards approximated $ i 1,710 million, of which $ i 1,466 million expire in fiscal years 2024 through 2043, and the remainder has no expiration. Gross foreign net operating loss carryforwards approximated $ i 302 million, of which $ i 116 million expire in fiscal years 2024 through 2043, and the remainder has no expiration. We also have tax credit carryforwards of approximately $ i 44 million which expire in fiscal years 2024 through 2038.

We have accumulated undistributed earnings of foreign subsidiaries aggregating approximately $ i 667 million at September 30, 2023. Our undistributed earnings are generally expected to be indefinitely reinvested outside of the United States, except for excess cash (net of applicable withholding taxes) not subject to regulatory requirements. Dividends after December 31, 2017 from foreign subsidiaries are generally not subject to U.S. federal income taxes. Accordingly, no deferred income taxes have been provided on these earnings, and due to the uncertainty of the manner in which the outside basis difference associated with these earnings would reverse, it is not currently practicable to estimate the tax liability that might be payable on the repatriation of these foreign earnings; however, we do not expect any tax due to be material.

i The following table summarizes the activity related to our gross unrecognized tax benefits as of September 30, 2023, October 1, 2022 and October 2, 2021 (in millions):

2023

2022

2021

Balance as of the beginning of the year

i 152

i 165

Increases related to current year tax positions

i 7

i 16

i 25

Increases related to prior year tax positions

i 1

i 20

i 7

Reductions related to prior year tax positions

( i 12)

( i 13)

( i 7)

Reductions related to settlements

i —

( i 3)

( i 1)

Reductions related to expirations of statutes of limitations

( i 17)

( i 20)

( i 37)

Balance as of the end of the year

i 131

i 152

The amount of unrecognized tax benefits, if recognized, that would impact our effective tax rate was $ i 98 million at September 30, 2023 and $ i 112 million at October 1, 2022. We classify interest and penalties on unrecognized tax benefits as income tax expense. At September 30, 2023, and October 1, 2022, before tax benefits, we had $ i 50 million and $ i 47 million, respectively, of accrued interest and penalties on unrecognized tax benefits.

In December 2021, we received an assessment from the Mexican tax authorities related to the 2015 sale of our direct and indirect equity interests in subsidiaries which held our Mexico operations. At September 30, 2023, the assessment totaled approximately $ i 488 million ( i 8.6 billion Mexican pesos), which includes tax, inflation adjustment, interest and penalties. We believe the assertions made in the assessment letter have no merit and will defend our positions through the Mexican administrative appeal process and litigation, if necessary. Based on our analysis of this assessment in accordance with FASB guidance related to unrecognized tax benefits, we have not recorded a liability related to the issue.

As of September 30, 2023, certain United States federal income tax returns are subject to examination for fiscal years 2019 through 2022. We are also subject to income tax examinations by major state and foreign jurisdictions for fiscal years 2014 through 2022 and 2018 through 2022, respectively. We do not expect material changes to our unrecognized tax benefits during the next twelve months.

On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was signed into law. The IRA made several changes to the U.S. tax code effective after December 31, 2022, including, but not limited to, a 15% minimum tax on large corporations with average annual financial statement income of more than $1 billion for a three tax-year period and a 1% excise tax on public company stock buybacks, which will be accounted for in treasury stock. These changes did not have any impact on our provision for income taxes or financial statements in fiscal 2023.

NOTE 11: i EARNINGS (LOSS) PER SHARE

The earnings and weighted average common shares used in the computation of basic and diluted earnings per share are as follows for fiscal years ended 2023, 2022 and 2021 (in millions, except per share data):

2023

2022

2021

Numerator:

Net income (loss)

( i 649)

i 3,249

i 3,060

Less: Net income (loss) attributable to noncontrolling interests

( i 1)

i 11

i 13

Net income (loss) attributable to Tyson

( i 648)

i 3,238

i 3,047

Less dividends declared:

Class A

i 554

i 539

i 532

Class B

i 122

i 117

i 113

Undistributed earnings (losses)

( i 1,324)

i 2,582

i 2,402

Class A undistributed earnings (losses)

( i 1,084)

i 2,122

i 1,977

Class B undistributed earnings (losses)

( i 240)

i 460

i 425

Total undistributed earnings (losses)

( i 1,324)

i 2,582

i 2,402

Denominator:

Denominator for basic earnings (loss) per share:

Class A weighted average shares

i 284

i 290

i 293

Class B weighted average shares

i 70

Denominator for diluted earnings (loss) per share:

Class A weighted average shares

i 284

i 290

i 293

Class B weighted average shares under if-converted method for diluted earnings (loss) per share(a)

—

i 70

Effect of dilutive securities: Stock options, restricted stock and performance units

i —

i 3

i 2

Denominator for diluted earnings (loss) per share – weighted average shares and assumed conversions(a)

i 284

i 363

i 365

Net income (loss) per share attributable to Tyson:

Class A Basic

( i 1.87)

i 9.18

i 8.57

Class B Basic

( i 1.68)

i 8.25

i 7.70

Diluted(a)

( i 1.87)

i 8.92

i 8.34

Dividends Declared Per Share:

Class A

i 1.940

i 1.855

i 1.805

Class B

i 1.746

i 1.670

i 1.625

(a) For fiscal 2023, as the Company is in a net loss position, the impact of the Class B shares under the if-converted method is antidilutive and therefore we have not assumed conversion. As a result, the Class B weighted average shares, dividends declared and undistributed losses were excluded for the purposes of calculating Net Income (Loss) Per Share Attributable to Tyson on a diluted basis.

Approximately i 9 million, i 2 million, and i 4 million of our stock-based compensation shares were antidilutive for fiscal 2023, 2022 and 2021. These shares were not included in the diluted earnings per share calculation.

We have i two classes of capital stock, Class A stock and Class B stock. Cash dividends cannot be paid to holders of Class B stock unless they are simultaneously paid to holders of Class A stock. The per share amount of cash dividends paid to holders of Class B stock cannot exceed i 90% of the cash dividends paid to holders of Class A stock.

We allocate undistributed earnings (losses) based upon a i 1 to i 0.9 ratio per share to Class A stock and Class B stock, respectively. We allocate undistributed earnings (losses) based on this ratio due to historical dividend patterns, voting control of Class B shareholders and contractual limitations of dividends to Class B stock.

NOTE 12: i DERIVATIVE FINANCIAL INSTRUMENTS

Our business operations give rise to certain market risk exposures mostly due to changes in commodity prices, foreign currency exchange rates and interest rates. We manage a portion of these risks through the use of derivative financial instruments to reduce our exposure to commodity price risk, foreign currency risk and interest rate risk. Our risk management programs are periodically reviewed by our Board of Directors’ Audit Committee. These programs and risks are monitored by senior management and may be revised as market conditions dictate. Our current risk management programs utilize various industry-standard models that take into account the implicit cost of hedging. Credit risks associated with our derivative contracts are not significant as we minimize counterparty exposure by dealing with credit-worthy counterparties and utilizing exchange traded instruments, margin accounts or letters of credit. Additionally, our derivative contracts are mostly short-term in duration and we generally do not make use of credit-risk-related contingent features. No significant concentrations of credit risk existed at September 30, 2023.

i We had the following aggregated outstanding notional amounts related to our derivative financial instruments (in millions, except soybean meal tons):

Metric

Commodity:

Corn

Bushels

i 65

i 44

Soybean Meal

Tons

i 956,630

i 532,700

Live Cattle

Pounds

i 319

i 280

Lean Hogs

Pounds

i 454

i 339

Foreign Currency

United States dollar

i 171

i 249

We recognize all derivative instruments as either assets or liabilities at fair value in the Consolidated Balance Sheets, with the exception of normal purchases and normal sales expected to result in physical delivery. For those derivative instruments that are designated and qualify as hedging instruments, we designate the hedging instrument based upon the exposure being hedged (i.e., cash flow hedge or fair value hedge). We designate certain forward contracts as follows:

•Cash Flow Hedges – include certain commodity forward and option contracts of forecasted purchases (i.e., grains), interest rate swaps and locks, and certain foreign exchange forward contracts.

•Fair Value Hedges – include certain commodity forward contracts of firm commitments (i.e., livestock).

Cash Flow Hedges

Derivative instruments are designated as hedges against changes in the amount of future cash flows related to procurement of certain commodities utilized in our production processes as well as interest rates to our variable rate debt. For the derivative instruments we designate and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses representing hedge ineffectiveness are recognized in earnings in the current period. Ineffectiveness related to our cash flow hedges was not significant during fiscal 2023, 2022 and 2021. As of September 30, 2023, we have $ i 12 million of realized losses related to treasury rate locks in connection with the issuance of the 2026, 2029 and 2048 Notes, which will be reclassified to earnings over the lives of these notes. During fiscal 2023, 2022 and 2021, we had no gains or losses recognized in OCI on derivatives designated as cash flow hedges.

Fair Value Hedges

We designate certain derivative contracts as fair value hedges of firm commitments to purchase livestock for harvest. Our objective of these hedges is to minimize the risk of changes in fair value created by fluctuations in commodity prices associated with fixed price livestock firm commitments. For these derivative instruments we designate and qualify as a fair value hedge, the gain or loss on the derivative, as well as the offsetting gain or loss on the hedged item attributable to the hedged risk, are recognized in earnings in the same period. We include the gain or loss on the hedged items (i.e., livestock purchase firm commitments) in the same line item, Cost of Sales, as the offsetting gain or loss on the related livestock forward position. Ineffectiveness related to our fair value hedges was not significant during fiscal 2023, 2022 and 2021. i The carrying amount of fair value hedge (assets) liabilities as of fiscal 2023, 2022 and 2021 were as follows (in millions):



Consolidated Balance Sheets Classification	2023		2022		2021
Inventory	$	i 16	$	( i 12)	$	( i 6)

Undesignated Positions

In addition to our designated positions, we also hold derivative contracts for which we do not apply hedge accounting. These include certain derivative instruments related to commodities price risk, including grains, livestock, energy and foreign currency risk. We mark these positions to fair value through earnings at each reporting date.

Reclassification to Earnings

The following table sets forth the total amounts of each income and expense line item presented in the Consolidated Statements of Income in which the effects of hedges are recorded for fiscal years ended 2023, 2022 and 2021(in millions):

Consolidated Statements of Income Classification

2023

2022

2021

Cost of Sales

i 50,250

i 46,614

i 40,523

Interest Expense

i 355

i 365

i 428

Other, net

( i 42)

( i 87)

( i 65)

/ i

The following table sets forth the pretax impact of the cash flow, fair value and undesignated derivative instruments in the Consolidated Statements of Income for fiscal years ended 2023, 2022 and 2021(in millions):

Consolidated Statements of Income Classification

2023

2022

2021

Cost of Sales

Gain (Loss) on cash flow hedges reclassified from OCI to Earnings:

Commodity contracts

i —

( i 1)

Gain (Loss) on fair value hedges:

Commodity contracts (a)

( i 19)

( i 29)

( i 55)

Gain (Loss) on derivatives not designated as hedging instruments:

Commodity contracts

( i 98)

i 254

i 70

Total

( i 117)

i 225

i 14

Interest Expense

Gain (Loss) on cash flow hedges reclassified from OCI to Earnings:

Interest rate contracts

( i 2)

( i 1)

Other, net

Gain (Loss) on derivatives not designated as hedging instruments:

Foreign exchange contracts

i 3

( i 9)

( i 5)

(a) Amounts represent gains/(losses) on commodity contracts designated as fair value hedges of firm commitments that were realized during the period presented, which were offset by a corresponding gain/(loss) on the underlying hedged inventory. Gains or losses related to changes in the fair value of unrealized commodity contracts, along with the offsetting gain or loss on the hedged inventory, are also marked-to-market through earnings with no impact on a net basis.

The fair value of all outstanding derivative instruments in the Consolidated Balance Sheets are included in Note 13: Fair Value Measurements.

NOTE 13: i FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels as follows:

Level 1 — Unadjusted quoted prices available in active markets for the identical assets or liabilities at the measurement date.

Level 2 — Other observable inputs available at the measurement date, other than quoted prices included in Level 1, either directly or indirectly, including:

•Quoted prices for similar assets or liabilities in active markets;

•Quoted prices for identical or similar assets in non-active markets;

•Inputs other than quoted prices that are observable for the asset or liability; and

•Inputs derived principally from or corroborated by other observable market data.

Level 3 — Unobservable inputs that cannot be corroborated by observable market data and reflect the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management’s estimates of market participant assumptions.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The fair value hierarchy requires the use of observable market data when available. In instances where the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement has been determined based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability.

The following tables set forth by level within the fair value hierarchy our financial assets and liabilities accounted for at fair value on a recurring basis according to the valuation techniques we used to determine their fair values as of September 30, 2023 and October 1, 2022 (in millions):

Level 1

Level 2

Level 3

Netting (a)

Total

Other Current Assets:

Derivative financial instruments:

Designated as hedges

i —

i 7

i —

( i 2)

i 5

Undesignated

i —

i 95

i —

( i 19)

i 76

Available for sale securities (current)

i —

i 15

i —

—

i 15

Other Assets:

Available for sale securities (non-current)

i —

i 59

i 30

—

i 89

Deferred compensation assets

i 27

i 375

i —

—

i 402

Total Assets

i 27

i 551

i 30

( i 21)

i 587

Other Current Liabilities:

Derivative financial instruments:

Designated as hedges

i —

i 27

i —

( i 27)

i —

Undesignated

i —

i 126

i —

( i 107)

i 19

Total Liabilities

i —

i 153

i —

( i 134)

i 19

Level 1

Level 2

Level 3

Netting (a)

Total

Other Current Assets:

Derivative financial instruments:

Designated as hedges

i —

i 14

i —

( i 6)

i 8

Undesignated

i —

i 154

i —

( i 58)

i 96

Available for sale securities (current)

i —

i 1

i —

—

i 1

Other Assets:

Available for sale securities (non-current)

i —

i 65

i 35

—

i 100

Deferred Compensation assets

i 38

i 327

i —

—

i 365

Total Assets

i 38

i 561

i 35

( i 64)

i 570

Other Current Liabilities:

Derivative financial instruments:

Designated as hedges

i —

i 2

i —

( i 2)

i —

Undesignated

i —

i 106

i —

( i 72)

i 34

Total liabilities

i —

i 108

i —

( i 74)

i 34

(a) Our derivative assets and liabilities are presented in our Consolidated Balance Sheets on a net basis when a legally enforceable master netting arrangement exists between the counterparty to a derivative contract and us. Additionally, at September 30, 2023, and October 1, 2022, we had $ i 113 million and $ i 10 million, respectively, of net cash collateral posted with various counterparties where master netting arrangements exist and held no cash collateral.

i The following table provides a reconciliation between the beginning and ending balance of marketable debt securities measured at fair value on a recurring basis in the table above that used significant unobservable inputs (Level 3) as of September 30, 2023 and October 1, 2022 (in millions):



	September 30, 2023		October 1, 2022
Balance at beginning of year	$	i 35	$	i 48
Total realized and unrealized gains (losses):
Included in other comprehensive income (loss)	i 1		( i 3)
Purchases	i 10		i 8
Settlements	( i 16)		( i 18)
Balance at end of year	$	i 30	$	i 35

The following methods and assumptions were used to estimate the fair value of each class of financial instrument:

Derivative Assets and Liabilities

Our derivative financial instruments primarily include exchange-traded and over-the-counter contracts which are further described in Note 12: Derivative Financial Instruments. We record our derivative financial instruments at fair value using quoted market prices, adjusted where necessary for credit and non-performance risk and internal models that use readily observable market inputs as their basis, including current and forward market prices and rates. We classify these instruments in Level 2 when quoted market prices can be corroborated utilizing observable current and forward commodity market prices on active exchanges or observable market transactions.

Available for Sale Securities

Our investments in marketable debt securities are classified as available-for-sale and are reported at fair value based on pricing models and quoted market prices adjusted for credit and non-performance risk. Short-term investments with maturities of less than i 12 months are included in Other current assets in the Consolidated Balance Sheets and primarily include certificates of deposit and commercial paper. All other marketable debt securities are included in Other Assets in the Consolidated Balance Sheets and have maturities ranging up to i 46 years.

We classify our investments in U.S. government, U.S. agency, certificates of deposit and commercial paper debt securities as Level 2 as fair value is generally estimated using discounted cash flow models that are primarily industry-standard models that consider various assumptions, including time value and yield curve as well as other readily available relevant economic measures. We classify certain corporate, asset-backed and other debt securities as Level 3 as there is limited activity or less observable inputs into valuation models, including current interest rates and estimated prepayment, default and recovery rates on the underlying portfolio or structured investment vehicle. Significant changes to assumptions or unobservable inputs in the valuation of our Level 3 instruments would not have a significant impact to our consolidated financial statements.

i The following table sets forth our available-for-sale securities’ amortized cost basis, fair value and unrealized gain (loss) by significant investment category as of September 30, 2023 and October 1, 2022 (in millions):

Amortized
Cost Basis

Fair
Value

Unrealized
Gain/(Loss)

Amortized
Cost Basis

Fair
Value

Unrealized
Gain/(Loss)

Available for Sale Securities:

Debt Securities:

United States Treasury and Agency

i 79

i 74

( i 5)

i 71

i 66

( i 5)

Corporate and Asset-Backed

i 31

i 30

( i 1)

i 37

i 35

( i 2)

Unrealized holding gains (losses), net of tax, are excluded from earnings and reported in OCI until the security is settled or sold. On a quarterly basis, we evaluate whether losses related to our available-for-sale securities are due to credit or noncredit factors. Losses on debt securities where we have the intent, or will more than likely be required, to sell the security prior to recovery, would be recorded as a direct write-off of amortized cost basis through earnings. Losses on debt securities where we do not have the intent, or would not more than likely be required to sell the security prior to recovery, would be further evaluated to determine whether the loss is credit or non-credit related. Credit-related losses would be recorded through an allowance for credit losses through earnings and non-credit related losses through OCI.

We consider many factors in determining whether a loss is credit-related, including the financial condition and near-term prospects of the issuer, borrower repayment characteristics for asset-backed securities, and our ability and intent to hold the investment for a period of time sufficient to allow for any anticipated recovery. We recognized no direct write-offs or allowances for credit losses in earnings in fiscal 2023, 2022 or 2021.

Deferred Compensation Assets

We maintain non-qualified deferred compensation plans for certain executives and other highly compensated team members. Investments are generally maintained within a trust and include money market funds, mutual funds and life insurance policies. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The investments are recorded at fair value based on quoted market prices and are included in Other Assets in the Consolidated Balance Sheets. We classify the investments which have observable market prices in active markets in Level 1 as these are generally publicly-traded mutual funds. The remaining deferred compensation assets are classified in Level 2, as fair value can be corroborated based on observable market data. Realized and unrealized gains (losses) on deferred compensation are included in earnings.

Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis

In addition to assets and liabilities that are recorded at fair value on a recurring basis, we record assets and liabilities at fair value on a nonrecurring basis. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges and, with respect to our equity investments without readily determinable fair values, recorded by applying the measurement alternative for which such investments are recorded at cost and adjusted for an observable price change in an orderly transaction for an identical or similar investment of the same issuer.

In fiscal 2023, we recorded goodwill impairment charges of $ i 333 million, $ i 210 million and $ i 238 million in our Beef and Chicken segments and International/Other, respectively. We estimated the fair value of our reporting units utilizing various valuation techniques, with the primary technique being an income approach (discounted cash flow method) and another technique being a market approach (guideline public company method), which incorporated significant unobservable Level 3 inputs. During fiscal 2022, we recognized gains of $ i 37 million in Other, net in the Consolidated Statements of Income, based upon observable price changes. Equity investments without readily determinable fair values are measured using Level 3 inputs and are included in Other Assets in the Consolidated Balance Sheets. We did not have any other significant measurements of assets or liabilities at fair value on a nonrecurring basis subsequent to their initial recognition during the twelve months ended September 30, 2023, October 1, 2022, or October 2, 2021.

Other Financial Instruments

i Fair value of our debt is principally estimated using Level 2 inputs based on quoted prices for those or similar instruments. Fair value and carrying value for our debt are as follows as of September 30, 2023 and October 1, 2022 (in millions):

Fair
Value

Carrying
Value

Fair
Value

Carrying
Value

Total Debt

i 8,693

i 9,506

i 7,762

i 8,321

Concentrations of Credit Risk

Our financial instruments exposed to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Our cash equivalents are in high quality securities placed with major banks and financial institutions. Concentrations of credit risk with respect to receivables are limited due to the large number of customers and their dispersion across geographic areas. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. At September 30, 2023, and October 1, 2022, i 15.9% and i 16.4%, respectively, of our net accounts receivable balance was due from Walmart Inc. No other single customer or customer group represented greater than i i 10 / % of net accounts receivable.

NOTE 14: i STOCK-BASED COMPENSATION

We issue shares under our stock-based compensation plans by issuing Class A stock from treasury. The total number of shares available for future grant under the Tyson Foods, Inc. 2000 Stock Incentive Plan (“Incentive Plan”) was i 6,923,370 at September 30, 2023.

Stock Options

Shareholders approved the Incentive Plan in January 2001. The Incentive Plan is administered by the Compensation and Leadership Development Committee of the Board of Directors (“Compensation Committee”). The Incentive Plan includes provisions for granting incentive stock options for shares of Class A stock at a price not less than the fair value at the date of grant. Nonqualified stock options may be granted at a price equal to or more than the fair value of Class A stock on the date the option is granted. Stock options under the Incentive Plan generally become exercisable ratably over i three years from the date of grant and must be exercised within i 10 years from the date of grant. Our policy is to recognize compensation expense on a straight-line basis over the requisite service period for the entire award. Forfeitures are recognized as they occur. i

Shares Under
Option

Weighted
Average Exercise
Price Per Share

Weighted Average Remaining Contractual Life (in Years)

Aggregate
Intrinsic Value
(in millions)

Outstanding, October 1, 2022

i 6,029,629

i 67.95

Exercised

( i 245,991)

i 47.15

Forfeited or expired

( i 942,905)

i 71.52

Granted

i 1,539,275

i 65.55

Outstanding, September 30, 2023

i 6,380,008

i 67.65

i 6.2

i 7

Exercisable, September 30, 2023

i 4,422,711

i 66.94

i 5.2

i 7

The weighted average grant-date fair value of options granted in fiscal 2023, 2022 and 2021 was $ i 15.82, $ i 16.53 and $ i 11.03, respectively. The fair value of each option grant is established on the date of grant using a binomial lattice method. We use historical volatility for a period of time comparable to the expected life of the option to determine volatility assumptions. Expected life is calculated based on the contractual term of each grant and takes into account the historical exercise and termination behavior of participants. Risk-free interest rates are based on the five-year Treasury bond rate. i Assumptions used in the fair value calculation are as of the grant dates and are outlined in the following table.


	2023		2022		2021
Expected life (in years)	i 4.5		i 4.4		i 4.3
Risk-free interest rate	i 3.9	%	i 1.1	%	i 0.3	%
Expected volatility	i 31.2	%	i 30.0	%	i 32.2	%
Expected dividend yield	i 2.9	%	i 2.4	%	i 3.4	%

We recognized stock-based compensation expense related to stock options, net of income taxes, of $ i 13 million, $ i 13 million and $ i 19 million for fiscal 2023, 2022 and 2021, respectively. The related tax benefit for fiscal 2023, 2022 and 2021 was $ i 3 million, $ i 3 million and $ i 4 million, respectively. We had i 1.2 million, i 1.5 million and i 1.9 million options vest in fiscal 2023, 2022 and 2021, respectively, with a grant date fair value of $ i 18 million, $ i 19 million and $ i 25 million, respectively.

In fiscal 2023, 2022 and 2021, we received cash of $ i 11 million, $ i 126 million and $ i 41 million, respectively, for the exercise of stock options. Shares are issued from treasury for stock option exercises. The related tax benefit realized from stock options exercised during fiscal 2023, 2022 and 2021, was $ i 1 million, $ i 12 million and $ i 5 million, respectively. The total intrinsic value of options exercised in fiscal 2023, 2022 and 2021, was $ i 1 million, $ i 22 million and $ i 20 million, respectively.

As of September 30, 2023, we had $ i 18 million of total unrecognized compensation cost related to stock option plans that will be recognized over a weighted average period of i 1.1 years.

Restricted Stock

We issue restricted stock at the market value as of the date of grant, with restrictions expiring over periods through fiscal 2026. Unearned compensation is recognized over the vesting period for the particular grant using a straight-line method.

Number of Shares

Weighted
Average Grant-
Date Fair Value
Per Share

Weighted Average
Remaining
Contractual Life
(in Years)

Aggregate
Intrinsic Value
(in millions)

Nonvested, October 1, 2022

i 1,606,531

i 76.36

Granted

i 1,006,545

i 62.23

Dividends

i 26,709

i 62.56

Vested

( i 669,511)

i 79.38

Forfeited

( i 334,359)

i 71.47

Nonvested, September 30, 2023

i 1,635,915

i 67.20

i 1.5

i 83

As of September 30, 2023, we had $ i 50 million of total unrecognized compensation cost related to restricted stock awards that will be recognized over a weighted average period of i 2.0 years.

We recognized stock-based compensation expense related to restricted stock, net of income taxes, of $ i 32 million, $ i 28 million and $ i 35 million for fiscal 2023, 2022 and 2021, respectively. The related tax benefit for fiscal 2023, 2022 and 2021 was $ i 9 million, $ i 7 million and $ i 9 million, respectively. We had i 0.7 million, i 0.9 million and i 0.5 million restricted stock awards vest in fiscal 2023, 2022 and 2021, respectively, with a grant date fair value of $ i 53 million, $ i 57 million and $ i 37 million, respectively.

Performance-Based Shares

We award performance-based shares of our Class A stock to certain team members. These awards are typically granted once a year. Performance-based shares vest based upon the passage of time and the achievement of performance or market performance criteria, ranging from i 0% to i 200%, as determined by the Compensation Committee prior to the date of the award. Vesting periods for these awards are i three years. We review progress toward the attainment of the performance criteria each quarter during the vesting period. When it is probable the minimum performance criteria for an award will be achieved, we begin recognizing the expense equal to the proportionate share of the total fair value of the Class A stock price on the grant date. The total expense recognized over the duration of performance awards will equal the Class A stock price on the date of grant multiplied by the number of shares ultimately awarded based on the level of attainment of the performance criteria. For grants with market performance criteria, the fair value is determined on the grant date and is calculated using the same inputs for expected volatility, expected dividend yield, and risk-free rate as stock options, noted above, with a duration of i three years. The total expense recognized over the duration of the award will equal the fair value, regardless if the market performance criteria is met.

i The following table summarizes the performance-based shares at the maximum award amounts based upon the respective performance share agreements. Actual shares that will vest depend on the level of attainment of the performance-based criteria.

Number of Shares

Weighted
Average Grant-
Date Fair Value
Per Share

Weighted Average
Remaining
Contractual Life
(in Years)

Aggregate
Intrinsic Value
(in millions)

Nonvested, October 1, 2022

i 1,781,519

i 58.13

Granted

i 938,835

i 48.80

Vested

( i 243,782)

i 90.05

Forfeited

( i 830,423)

i 50.74

Nonvested, September 30, 2023

i 1,646,149

i 51.81

i 1.2

i 83

We recognized stock-based compensation expense related to performance shares, net of income taxes, of $ i 2 million, $ i 37 million and $ i 19 million for fiscal 2023, 2022 and 2021, respectively. The related tax benefit for fiscal 2023 was inconsequential. The related tax benefit for fiscal 2022 and 2021 was $ i 7 million and $ i 4 million, respectively. As of September 30, 2023, we had $ i 6 million of total unrecognized compensation based upon our progress toward the attainment of criteria related to performance-based share awards that will be recognized over a weighted average period of i 1.6 years.

NOTE 15: i PENSIONS AND OTHER POSTRETIREMENT BENEFITS

We have i four defined benefit pension plans consisting of i one frozen and noncontributory funded qualified plan and i three frozen unfunded non-qualified plans. The benefits provided under these plans are based on a formula using years of service and either a specified benefit rate or compensation level. The non-qualified defined benefit plans are for certain officers and use a formula based on years of service and final average salary. We also have other postretirement benefit plans for which substantially all of our team members may receive benefits if they satisfy applicable eligibility criteria. The postretirement healthcare plans are contributory with participants’ contributions adjusted when deemed necessary.

We have defined contribution retirement programs for various groups of team members. We recognized expenses of $ i 113 million, $ i 114 million and $ i 106 million in fiscal 2023, 2022 and 2021, respectively.

We use a fiscal year end measurement date for our defined benefit plans and other postretirement plans. We recognize the effect of actuarial gains and losses into earnings immediately for other postretirement plans rather than amortizing the effect over future periods. Other postretirement benefits include postretirement medical costs and life insurance.

During fiscal 2021, we amended one of the Company’s other postretirement benefit plans, which resulted in the recognition of a gain of $ i 34 million, recorded in Other, net in our Consolidated Statements of Income.

Benefit Obligations and Funded Status

i The following table provides a reconciliation of the changes in the plans’ benefit obligations, assets and funded status as of September 30, 2023 and October 1, 2022 (in millions):

Pension Benefits

Other Postretirement

Qualified

Non-Qualified

Benefits

2023

2022

2023

2022

2023

2022

Change in benefit obligation

Benefit obligation at beginning of year

i 17

i 28

i 166

i 220

i 55

i 65

Service cost

i —

i 2

i 1

Interest cost

i 1

i 8

i 6

i 1

Actuarial (gain)/loss

i 1

( i 11)

( i 3)

( i 47)

( i 5)

( i 8)

Benefits paid

( i 1)

( i 13)

( i 3)

( i 4)

Benefit obligation at end of year

i 18

i 17

i 158

i 166

i 50

i 55

Change in plan assets

Fair value of plan assets at beginning of year

i 24

i 33

i —

Actual return on plan assets

i 4

( i 9)

i —

Employer contributions

i —

i 1

i 13

i 3

i 4

Benefits paid

( i 1)

( i 13)

( i 3)

( i 4)

Fair value of plan assets at end of year

i 27

i 24

i —

Funded status

i 9

i 7

( i 158)

( i 166)

( i 50)

( i 55)

i Amounts recognized in the Consolidated Balance Sheets as of September 30, 2023 and October 1, 2022 consist of (in millions):

Pension Benefits

Other Postretirement

Qualified

Non-Qualified

Benefits

2023

2022

2023

2022

2023

2022

Other assets

i 9

i 7

i —

Other current liabilities

i —

( i 13)

( i 2)

( i 3)

Other liabilities

i —

( i 145)

( i 153)

( i 48)

( i 52)

Total assets (liabilities)

i 9

i 7

( i 158)

( i 166)

( i 50)

( i 55)

Pre-tax amounts recognized in Accumulated Other Comprehensive Income as of September 30, 2023 and October 1, 2022 consist of (in millions):



	Pension Benefits								Other Postretirement
	Qualified				Non-Qualified				Benefits
	2023		2022		2023		2022		2023		2022
Accumulated other comprehensive (income)/loss:
Actuarial (gain) loss	$	i 1	$	i 2	$	( i 15)	$	( i 15)	$	i 9	$	i 13
Prior service (credit) cost	i —		i —		i 1		i 2		( i 5)		( i 5)
Total accumulated other comprehensive (income)/loss:	$	i 1	$	i 2	$	( i 14)	$	( i 13)	$	i 4	$	i 8

We had i three pension plans as of September 30, 2023 and October 1, 2022, that had an accumulated benefit obligation in excess of plan assets. i Plans with accumulated benefit obligations in excess of plan assets are as follows (in millions):

Pension Benefits

Qualified

Non-Qualified

2023

2022

2023

2022

Projected benefit obligation

i —

i 158

i 166

Accumulated benefit obligation

i —

i 158

i 166

Fair value of plan assets

i —

The accumulated benefit obligation for all qualified pension plans was $ i 18 million and $ i 17 million at September 30, 2023, and October 1, 2022, respectively.

Net Periodic Benefit Cost (Credit)

i Components of net periodic benefit cost (credit) for pension and postretirement benefit plans recognized in the Consolidated Statements of Income are as follows for fiscal years ended 2023, 2022 and 2021 (in millions):

Pension Benefits

Other Postretirement

Qualified

Non-Qualified

Benefits

2023

2022

2021

2023

2022

2021

2023

2022

2021

Service cost

i —

i 2

i 1

i 2

Interest cost

i 1

i —

i 8

i 6

i 1

Expected return on plan assets

( i 1)

i —

Amortization of prior service cost

i —

i 1

i 5

i 4

( i 2)

Recognized actuarial loss (gain), net

i —

( i 3)

i 3

i 4

( i 5)

( i 8)

i —

Recognized settlement gain

i —

( i 34)

Net periodic benefit cost (credit)

i —

i 6

i 10

i 11

i 3

( i 2)

( i 33)

Each of the components other than the service cost component were recorded in the Consolidated Statements of Income in Other, net. As of September 30, 2023, we expect i no amounts to be reclassified into earnings within the next 12 months related to net periodic benefit cost (credit) for the qualified pension plans. As of September 30, 2023, the amounts expected to be reclassified into earnings within the next 12 months related to net periodic benefit cost (credit) for the non-qualified pension plans and the other postretirement benefit plans are not significant.

Assumptions

i Weighted average assumptions are as follows for fiscal years ended 2023, 2022 and 2021:


	Pension Benefits												Other Postretirement
	Qualified						Non-Qualified						Benefits
	2023		2022		2021		2023		2022		2021		2023		2022		2021
Discount rate to determine net periodic benefit cost	i 5.20	%	i 2.00	%	i 1.70	%	i 5.42	%	i 2.83	%	i 2.63	%	i 4.59	%	i 2.07	%	i 1.95	%
Discount rate to determine benefit obligations	i 5.70	%	i 5.20	%	i 2.00	%	i 5.79	%	i 5.42	%	i 2.83	%	i 4.92	%	i 4.59	%	i 2.07	%
Rate of compensation increase	n/a		n/a		n/a		n/a		n/a		n/a		n/a		n/a		n/a
Expected return on plan assets	i 5.20	%	i 2.00	%	i 1.70	%	n/a		n/a		n/a		n/a		n/a		n/a

To determine the expected return on plan assets assumption, we first examined historical rates of return for the various asset classes within the plans. We then determined a long-term projected rate-of-return based on expected returns. Our discount rate assumptions used to account for pension and other postretirement benefit plans reflect the rates at which the benefit obligations could be effectively settled. The discount rates for our plans were determined using a cash flow matching technique whereby the rates of a yield curve, developed from high-quality debt securities, were applied to the benefit obligations to determine the appropriate discount rate.

We have i eight other postretirement benefit plans, of which i five are healthcare and life insurance related. i Two of these plans, with benefit obligations totaling $ i 9 million at September 30, 2023, were not impacted by healthcare cost trend rates as i one consists of fixed annual payments and i one is life insurance related. i One of the healthcare plans, with benefit obligations less than $ i 1 million at September 30, 2023, was not impacted by healthcare cost trend rates due to previous plan amendments. The remaining i two plans, with benefit obligations less than $ i 1 million and $ i 3 million, at September 30, 2023, utilized assumed healthcare cost trend rates of i 7.1% and i 7.0%, respectively. The healthcare cost trend rates for the two plans will be grading down to an ultimate rate of i i 4.5 / % in 2032 and 2031, respectively.

Contributions

Our policy is to fund at least the minimum contribution required to meet applicable federal employee benefit and local tax laws. In our sole discretion, we may from time to time fund additional amounts. Expected contributions to pension plans for fiscal 2024 are approximately $ i 15 million. For fiscal 2023, 2022 and 2021, we funded $ i 13 million, $ i 13 million and $ i 15 million, respectively, to pension plans.

Estimated Future Benefit Payments

The following benefit payments are expected to be paid (in millions):

Pension Benefits

Other Postretirement

Qualified

Non-Qualified

Benefits

2024

i 1

i 14

i 2

2025

i 1

i 14

i 2

2026

i —

i 14

i 3

2027

i —

i 13

i 2

2028

i —

i 13

i 2

2029-2033

i 5

i 62

i 7

The above benefit payments for other postretirement benefit plans are not expected to be offset by Medicare Part D subsidies in fiscal 2024.

Multi-Employer Plan

Additionally, we participate in i one multi-employer plan that provides defined benefits to certain team members covered by collective bargaining agreements. Such plans are usually administered by a board of trustees composed of the management of the participating companies and labor representatives.

The risks of participating in multi-employer plans are different from single-employer plans. Assets contributed to the multi-employer plan by one employer may be used to provide benefits to team members of other participating employers. If a participating employer stops contributing to the plan, the unfunded obligation of the plan may be borne by the remaining participating employers. If we stop participating in a plan, we may be required to pay that plan an amount based on the underfunded status of the plan, referred to as a withdrawal liability.

The net pension cost of the plan is equal to the annual contributions determined in accordance with the provisions of negotiated labor contracts. Contributions to the plan were $ i i 2 / million in fiscal 2023 and fiscal 2022. Assets contributed to such plans are not segregated or otherwise restricted to provide benefits only to our team members. The future cost of the plans is dependent on a number of factors including the funded status of the plans and the ability of the other participating companies to meet ongoing funding obligations.

Our participation in the multi-employer plan for fiscal 2023 is outlined below. The EIN/Pension Plan Number column provides the Employer Identification Number (“EIN”) and the three-digit plan number. The most recent Pension Protection Act (“PPA”) zone status available in fiscal 2023 and fiscal 2022 is for the plan’s year beginning January 1, 2023, and 2022, respectively. The zone status is based on information that we have received from the plan and is certified by the plan’s actuaries. Among other factors, plans in the red zone are generally less than 65 percent funded. Plans that are critical and declining status are projected to have an accumulated funding deficiency. The FIP/RP Status column indicates plans for which a financial improvement plan (“FIP”) or rehabilitation plan (“RP”) is either pending or has been implemented. The last column lists the expiration date of the collective-bargaining agreement to which the plan is subject.

i In addition to regular contributions, we could be obligated to pay additional contributions (known as complete or partial withdrawal liabilities) if it has unfunded vested benefits.

PPA Zone Status

FIP/RP Status

Contributions
(in millions)

Surcharge Imposed

Pension Fund Plan Name

EIN/Pension Plan Number

2023

2022

Implemented

2023

2022

2021

2023

Expiration Date of Collective Bargaining Agreement

Bakery and Confectionery Union and Industry International Pension Fund

52-6118572/001

Red

Nov 2012

$ i 2

$ i 1

i 5%

i 2024-08-02

NOTE 16: i COMPREHENSIVE INCOME (LOSS)

i The components of accumulated other comprehensive income (loss) as of September 30, 2023 and October 1, 2022 are as follows (in millions):



	2023		2022
Accumulated other comprehensive income (loss), net of taxes:
Unrealized net hedging loss	$	( i 10)	$	( i 12)
Unrealized net gain (loss) on investments	( i 5)		( i 6)
Currency translation adjustment	( i 252)		( i 281)
Postretirement benefits reserve adjustments	i 7		i 2
Total accumulated other comprehensive income (loss)	$	( i 260)	$	( i 297)

The before and after tax changes in the components of other comprehensive income (loss) are as follows for fiscal years ended 2023, 2022 and 2021 (in millions):

2023

2022

2021

Before Tax

Tax

After Tax

Before Tax

Tax

After Tax

Before Tax

Tax

After Tax

Derivatives accounted for as cash flow hedges:

(Gain) loss reclassified to interest expense

i 2

i —

i 2

i 1

i —

i 1

i —

i 1

(Gain) loss reclassified to cost of sales

i —

i 1

i —

i 1

Investments:

Unrealized gain (loss)

i 1

i —

i 1

( i 8)

i 1

( i 7)

( i 1)

i —

( i 1)

Currency translation:

Translation adjustment

i 29

i —

i 29

( i 166)

i 4

( i 162)

i 17

i —

i 17

Postretirement benefits:

Unrealized gain (loss)

i 6

( i 1)

i 5

i 58

( i 15)

i 43

i 10

( i 2)

i 8

Pension settlement reclassified to other (income) expense

i —

( i 26)

i 7

( i 19)

Total other comprehensive income (loss)

i 38

( i 1)

i 37

( i 115)

( i 10)

( i 125)

i 2

i 5

i 7

NOTE 17: i SEGMENT REPORTING

We operate in i four reportable segments: Beef, Pork, Chicken, and Prepared Foods. We measure segment profit as operating income (loss). International/Other primarily includes our foreign operations in Australia, China, Malaysia, Mexico, the Netherlands, South Korea, Thailand and the Kingdom of Saudi Arabia, third-party merger and integration costs and corporate overhead related to Tyson New Ventures, LLC.

Beef

Pork

Chicken

Prepared Foods

We allocate expenses related to corporate activities to the segments, except for third-party merger and integration costs of $ i 3 million, $ i 5 million and $ i 2 million in fiscal 2023, 2022 and 2021, respectively, and corporate overhead related to Tyson New Ventures, LLC, which are included in International/Other. Intersegment sales transactions, which were at market prices, are included in the segment sales in the table below. Assets and additions to property, plant and equipment relating to corporate activities remain in International/Other.

i Information on segments and a reconciliation to income from continuing operations before income taxes are as follows for fiscal years ended 2023, 2022 and 2021 (in millions):

Beef

Pork

Chicken

Prepared
Foods

International/Other

Intersegment
Sales

Consolidated

2023

Sales

i 19,325

i 5,768

i 17,060

i 9,845

i 2,515

( i 1,632)

i 52,881

Operating Income (Loss)

( i 91)

( i 139)

( i 770)

i 823

( i 218)

( i 395)

Total Other (Income) Expense

i 283

Income (Loss) before Income Taxes

( i 678)

Depreciation and amortization

i 128

i 68

i 693

i 373

i 67

i 1,329

Total Assets

i 3,772

i 1,696

i 12,143

i 15,198

i 3,442

i 36,251

Additions to property, plant and equipment

i 169

i 62

i 834

i 578

i 296

i 1,939

2022

Sales

i 19,854

i 6,414

i 16,961

i 9,689

i 2,355

( i 1,991)

i 53,282

Operating Income (Loss)

i 2,502

i 193

i 955

i 746

i 14

i 4,410

Total Other (Income) Expense

i 261

Income before Income Taxes

i 4,149

Depreciation and amortization

i 128

i 70

i 563

i 372

i 58

i 1,191

Total Assets

i 3,883

i 1,697

i 12,386

i 14,920

i 3,935

i 36,821

Additions to property, plant and equipment

i 136

i 82

i 906

i 456

i 307

i 1,887

2021

Sales

i 17,999

i 6,277

i 13,733

i 8,853

i 1,990

( i 1,803)

i 47,049

Operating Income (Loss)

i 3,240

i 328

( i 625)

i 1,456

( i 3)

i 4,396

Total Other (Income) Expense

i 355

Income before Income Taxes

i 4,041

Depreciation and amortization

i 108

i 61

i 564

i 385

i 77

i 1,195

Total Assets

i 3,678

i 1,583

i 11,373

i 14,630

i 5,045

i 36,309

Additions to property, plant and equipment

i 246

i 100

i 518

i 237

i 108

i 1,209

Our largest customer, Walmart Inc., accounted for i 18.6%, i 17.7% and i 18.3% of consolidated sales in fiscal 2023, 2022 and 2021, respectively. Sales to Walmart Inc. were included in all the segments. Any extended discontinuance of sales to this customer could, if not replaced, have a material impact on our operations.

The majority of our operations are domiciled in the United States. Approximately i i i 95 / / % of sales to external customers for each of fiscal 2023, 2022 and 2021 were sourced from the United States. Approximately $ i 26.1 billion and $ i 25.7 billion of long-lived assets were located in the United States at September 30, 2023, and October 1, 2022, respectively. Excluding goodwill and intangible assets, long-lived assets located in the United States totaled approximately $ i 10.5 billion and $ i 9.5 billion at September 30, 2023, and October 1, 2022, respectively. Approximately $ i 1.4 billion and $ i 1.5 billion of long-lived assets were located in foreign locations, primarily Brazil, China, the European Union, Malaysia, New Zealand and Thailand at September 30, 2023, and October 1, 2022, respectively. Excluding goodwill and intangible assets, long-lived assets in foreign countries totaled approximately $ i 1,101 million and $ i 916 million at September 30, 2023, and October 1, 2022, respectively.

We sell certain products in foreign markets, primarily Australia, Canada, Central America, Chile, China, the European Union, the United Kingdom, Japan, Mexico, Malaysia, the Middle East, Singapore, South Korea, Taiwan and Thailand. Our export sales from the United States totaled $ i 5.1 billion, $ i 5.8 billion and $ i 4.9 billion for fiscal 2023, 2022 and 2021, respectively. Substantially all of our export sales are facilitated through unaffiliated brokers, marketing associations and foreign sales staffs. Sales of products produced in a country other than the United States were less than i i i 10 / / % of consolidated sales for each of fiscal 2023, 2022 and 2021.

i The following tables further disaggregate our sales to customers by major distribution channels (in millions):

Twelve months ended September 30, 2023

Retail(a)

Foodservice(b)

International(c)

Industrial and Other(d)

Intersegment

Total

Beef

i 8,947

i 4,839

i 2,633

i 2,395

i 511

i 19,325

Pork

i 1,677

i 477

i 1,235

i 1,338

i 1,041

i 5,768

Chicken

i 7,483

i 6,589

i 1,007

i 1,901

i 80

i 17,060

Prepared Foods

i 5,795

i 3,690

i 213

i 147

i —

i 9,845

International/Other

i —

i 2,515

i —

i 2,515

Intersegment

—

( i 1,632)

Total

i 23,902

i 15,595

i 7,603

i 5,781

i —

i 52,881

Twelve months ended October 1, 2022

Retail(a)

Foodservice(b)

International(c)

Industrial and Other(d)

Intersegment

Total

Beef

i 8,687

i 4,940

i 3,247

i 2,439

i 541

i 19,854

Pork

i 1,817

i 516

i 1,180

i 1,616

i 1,285

i 6,414

Chicken

i 7,194

i 6,475

i 1,131

i 1,996

i 165

i 16,961

Prepared Foods

i 5,587

i 3,751

i 191

i 160

i —

i 9,689

International/Other

i —

i 2,355

i —

i 2,355

Intersegment

—

( i 1,991)

Total

i 23,285

i 15,682

i 8,104

i 6,211

i —

i 53,282

Twelve months ended October 2, 2021

Retail(a)

Foodservice(b)

International(c)

Industrial and Other(d)

Intersegment

Total

Beef

i 8,779

i 4,326

i 2,720

i 1,719

i 455

i 17,999

Pork

i 1,787

i 474

i 1,173

i 1,563

i 1,280

i 6,277

Chicken

i 6,112

i 5,566

i 770

i 1,217

i 68

i 13,733

Prepared Foods

i 5,231

i 3,311

i 140

i 171

i —

i 8,853

International/Other

i —

i 1,990

i —

i 1,990

Intersegment

—

( i 1,803)

Total

i 21,909

i 13,677

i 6,793

i 4,670

i —

i 47,049

(a) Includes sales to consumer products and food retailers, such as grocery retailers, warehouse club stores, and internet-based retailers.

(b) Includes sales to foodservice distributors, restaurant operators, hotel chains and noncommercial foodservice establishments such as schools, convenience stores, healthcare facilities and the military.

(c) Includes sales to international markets related to internationally produced products or export sales of domestically produced products.

(d) Includes sales to industrial food processing companies that further process our product to sell to end consumers and any remaining sales not included in the Retail, Foodservice or International categories. For fiscal 2023 and 2021, the Chicken segment included a $ i 156 million and $ i 545 million reduction in Other due to the recognition of legal contingency accruals, respectively.

NOTE 18: i SUPPLEMENTAL CASH FLOWS INFORMATION

i The following table summarizes cash payments for interest and income taxes for fiscal years ended 2023, 2022 and 2021 (in millions):



	2023		2022		2021
Interest, net of amounts capitalized	$	i 340	$	i 363	$	i 444
Income taxes, net of refunds	i 46		i 1,216		i 683

NOTE 19: i TRANSACTIONS WITH RELATED PARTIES

We have related party leases for i two wastewater facilities with an entity owned by the Donald J. Tyson Revocable Trust (for which Mr. John Tyson, Chairman of the Company, is a trustee), Berry Street Waste Water Treatment Plant, LP ( i 90% of which is owned by the TLP), and the sisters of Mr. Tyson. As of September 30, 2023 and October 1, 2022, one lease was classified as a finance lease with a debt balance of $ i i 6 / million which is primarily recognized as Long-term debt in our Consolidated Balance Sheet. The other lease was classified as an operating lease with a lease liability balance of $ i 2 million and $ i 3 million as of September 30, 2023 and October 1, 2022, respectively, which is primarily recognized within Other Liabilities in our Consolidated Balance Sheet. Total payments of approximately $ i i i 1 / / million in each of fiscal 2023, 2022 and 2021 were paid to lease the facilities.

As of September 30, 2023, the TLP, of which John Tyson and director Barbara Tyson are general partners, owned i 70 million shares, or i 99.985% of our outstanding Class B stock and, along with the members of the Tyson family, owned i 6.9 million shares of Class A stock, giving it control of approximately i 71.74% of the total voting power of our outstanding voting stock.

In fiscal 2023, 2022 and 2021, the Company provided administrative services to the TLP, the beneficial owner of i 70 million shares of Class B stock, and the TLP, through TLP Investment, L.P., reimbursed the Company $ i i i 0.2 / / million in each of fiscal 2023 , 2022 and 2021.

NOTE 20: i COMMITMENTS AND CONTINGENCIES

Commitments

We guarantee obligations of certain outside third parties, consisting primarily of grower loans, which are substantially collateralized by the underlying assets. The remaining terms of the underlying obligations cover periods up to 8 years, and the maximum potential amount of future payments as of September 30, 2023, was i not significant. The likelihood of material payments under these guarantees is not considered probable. At September 30, 2023, and October 1, 2022, i i no / significant liabilities for guarantees were recorded.

We have cash flow assistance programs in which certain livestock suppliers participate. Under these programs, we pay an amount for livestock equivalent to a standard cost to grow such livestock during periods of low market sales prices. The amounts of such payments that are in excess of the market sales price are recorded as receivables and accrue interest. Participating suppliers are obligated to repay these receivables balances when market sales prices exceed this standard cost, or upon termination of the agreement. Our maximum commitment associated with these programs is limited to the fair value of each participating livestock supplier’s net tangible assets. The potential maximum obligation as of September 30, 2023, was approximately $ i 295 million. The total receivables under these programs were $ i 12 million and $ i 6 million at September 30, 2023 and October 1, 2022, respectively. These receivables are included, net of allowance for uncollectible amounts, in Accounts Receivable in our Consolidated Balance Sheets. Even though these programs are limited to the net tangible assets of the participating livestock suppliers, we also manage a portion of our credit risk associated with these programs by obtaining security interests in livestock suppliers’ assets. After analyzing residual credit risks and general market conditions, we have recorded an allowance for these program's estimated uncollectible receivables of $ i 8 million at September 30, 2023 and i no allowance for these programs at October 1, 2022, respectively.

When constructing new facilities or making major enhancements to existing facilities, we will occasionally enter into incentive agreements with local government agencies in order to reduce certain state and local tax expenditures. These funds are generally considered restricted cash, which is reported in the Consolidated Balance Sheets in Other Assets. We had i i no / deposits at September 30, 2023 and October 1, 2022. Additionally, under certain agreements, we transfer the related assets to various local government entities and receive Industrial Revenue Bonds. We immediately lease the facilities from the local government entities and have an option to re-purchase the facilities for a nominal amount upon tendering the Industrial Revenue Bonds to the local government entities at various predetermined dates. The Industrial Revenue Bonds and the associated obligations for the leases of the facilities offset, and the underlying assets remain in property, plant and equipment. At September 30, 2023, total amounts under these types of arrangements totaled $ i 797 million.

Additionally, we enter into other purchase commitments for various items such as grains, livestock contracts and variable livestock grower commitments that are estimable and have a remaining term in excess of one year, which as of September 30, 2023 were (in millions):



	Purchase Obligations
2024	$	i 424
2025	i 293
2026	i 151
2027	i 79
2028	i 50
2029 and beyond	i 149
Total	$	i 1,146

Contingencies

In the normal course of business, we are involved in various claims, lawsuits, investigations and legal proceedings, including those specifically identified below. Each quarter, we determine whether to accrue for loss contingencies based on our assessment of whether the potential loss is probable, reasonably possible or remote and to the extent a loss is probable, whether it is reasonably estimable. We record accruals in the Company’s Consolidated Financial Statements for matters that we conclude are probable and the financial impact is reasonably estimable. Regardless of the manner of resolution, frequently the most significant changes in the status of a matter may occur over a short time period, often following a lengthy period of little substantive activity. While these accruals reflect the Company’s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters. Listed below are certain claims made against the Company for which the magnitude of the potential exposure could be material to the Company’s Consolidated Financial Statements.

Broiler Antitrust Civil Litigation

Beginning in September 2016, a series of putative federal class action lawsuits styled In re Broiler Chicken Antitrust Litigation (the “Broiler Antitrust Civil Litigation”) were filed in the United States District Court for the Northern District of Illinois against us and certain of our poultry subsidiaries, as well as several other poultry processing companies. The operative complaints, which have been amended throughout the litigation, contain allegations that, among other things, assert that beginning in January 2008, the defendants conspired and combined to fix, raise, maintain, and stabilize the price of broiler chickens in violation of United States antitrust laws. The plaintiffs also allege that defendants “manipulated and artificially inflated a widely used Broiler price index, the Georgia Dock.” The plaintiffs further allege that the defendants concealed this conduct from the plaintiffs and the members of the putative classes. The plaintiffs seek treble damages, injunctive relief, pre- and post-judgment interest, costs, and attorneys’ fees on behalf of the putative classes. In addition, the complaints on behalf of the putative classes of indirect purchasers include causes of action under various state unfair competition laws, consumer protection laws, and unjust enrichment common laws. Since the original filing, certain putative class members have opted out of the matter and are proceeding with individual direct actions making similar claims, and others may do so in the future. The first trial in this matter, which involves claims brought by the Direct Purchaser Plaintiff Class and certain direct-action plaintiffs, began on September 12, 2023. The Company did not participate in the first trial as it had settled all of its claims with the plaintiffs in the first trial.

Settlements

On January 19, 2021, we announced that we had reached agreements to settle certain class claims related to the Broiler Antitrust Civil Litigation. Settlement terms were reached with the putative Direct Purchaser Plaintiff Class, the putative Commercial and Institutional Indirect Purchaser Plaintiff Class and the putative End-User Plaintiff Class (collectively, the “Classes”). Under the terms of the settlements, we agreed to pay the Classes an aggregate amount of $ i 221.5 million in settlement of all outstanding claims brought by the Classes. On February 23, 2021, March 22, 2021 and October 15, 2021, the Court granted preliminary approval of the settlements with the putative Direct Purchaser Plaintiff Class, the putative End-User Plaintiff Class and the putative Commercial and Institutional Indirect Purchaser Plaintiff Class, respectively. On June 29, 2021, December 20, 2021 and April 18, 2022, the Court granted final approval to the settlements with the Direct Purchaser Plaintiff Class, the End-User Plaintiff Class and the Commercial and Institutional Indirect Purchaser Plaintiff Class, respectively. The foregoing settlements do not settle claims made by plaintiffs who opt out of the Classes in the Broiler Antitrust Civil Litigation.

We are currently pursuing settlement discussions with the remaining opt-out plaintiffs with respect to the remaining claims. While we do not admit any liability as part of the settlements, we believe that the settlements were in the best interests of the Company and its shareholders to avoid the uncertainty, risk, expense and distraction of protracted litigation. During fiscal years 2023 and 2021, the Company recorded aggregate legal contingency accruals of $ i 146 million and $ i 545 million, respectively, for claims related to this matter. Additionally, during fiscal years 2023, 2022 and 2021, the Company reduced its total recorded legal contingency accrual by $ i 94 million, $ i 343 million and $ i 80 million, respectively, for amounts it had paid related to this matter. Accordingly, at September 30, 2023 and October 1, 2022, the legal contingency accrual for claims related to this matter was $ i 174 million and $ i 122 million, respectively.

Government Investigations

U.S. Department of Justice (“DOJ”) Antitrust Division. On June 21, 2019, the DOJ filed a motion to intervene and sought a limited stay of discovery in the Broiler Antitrust Civil Litigation, which the court granted in part. Subsequently, we received a grand jury subpoena from the DOJ seeking additional documents and information related to the chicken industry. On June 2, 2020, a grand jury for the District of Colorado returned an indictment charging four individual executives employed by two other poultry processing companies with conspiracy to engage in bid-rigging in violation of federal antitrust laws. On June 10, 2020, we announced that we uncovered information in connection with the grand jury subpoena that we had previously self-reported to the DOJ and have been cooperating with the DOJ as part of our application for leniency under the DOJ’s Corporate Leniency Program. Subsequently, the DOJ has announced indictments against additional individuals, as well as other poultry processing companies, alleging a conspiracy to fix prices and rig bids for broiler chicken products from at least 2012 until at least early 2019. In August 2021, the Company was granted conditional leniency by the DOJ for the matters we self-reported, which means that provided the Company continues to cooperate with the DOJ, neither the Company nor any of our cooperating employees will face prosecution or criminal fines or penalties. We continue to cooperate with the DOJ in connection with the ongoing federal antitrust investigation.

State Matters. The Offices of the Attorneys General in New Mexico, Alaska and Washington have filed complaints against us and certain of our poultry subsidiaries, as well as several other poultry processing companies and Agri Stats, Inc., an information services provider (“Agri Stats”). The complaints are based on allegations similar to those asserted in the Broiler Antitrust Civil Litigation and allege violations of state antitrust, unfair trade practice, and unjust enrichment laws. In October 2022, we reached an agreement to settle all claims with the Washington Attorney General for $ i 10.5 million for which the Company recorded an accrual in its Consolidated Financial Statements as of October 1, 2022, The Company paid the settlement during fiscal 2023. While we do not admit any liability as part of the settlement, we believe that the settlement was in the best interests of the Company and its shareholders to avoid the uncertainty, risk, expense and distraction of protracted litigation. We are cooperating with various state governmental agencies and officials, including the Offices of the Attorneys General for Florida and Louisiana, investigating or otherwise seeking information, testimony and/or documents, regarding the conduct alleged in the Broiler Antitrust Civil Litigation and related matters. While the Company believes it has meritorious defenses to the claims that have been made, we are exploring whether it is possible to resolve them in such a way that will serve the best interests of the Company and its shareholders and avoid the uncertainty, risk, expense and distraction of protracted litigation. As of September 30, 2023, the Company recorded an accrual for the estimated probable losses that it expects to incur for this matter in the Company's Consolidated Financial Statements.

Broiler Chicken Grower Litigation

On January 27, 2017 and March 26, 2017, putative class action complaints were filed against us and certain of our poultry subsidiaries, as well as several other vertically integrated poultry processing companies, in the United States District Court for the Eastern District of Oklahoma styled In re Broiler Chicken Grower Litigation. The plaintiffs allege, among other things, that the defendants colluded not to compete for broiler raising services “with the purpose and effect of fixing, maintaining, and/or stabilizing grower compensation below competitive levels.” The plaintiffs also allege that the defendants “agreed to share detailed data on [g]rower compensation with one another, with the purpose and effect of artificially depressing [g]rower compensation below competitive levels.” The plaintiffs contend these alleged acts constitute violations of the Sherman Antitrust Act and Section 202 of the Grain Inspection, Packers and Stockyards Act of 1921. The plaintiffs are seeking treble damages, pre- and post-judgment interest, costs, and attorneys’ fees on behalf of the putative class. Additional named plaintiffs filed similar class action complaints in federal district courts in North Carolina, Colorado, Kansas and California. All actions were subsequently consolidated in the Eastern District of Oklahoma. In June 2021, we reached an agreement to settle with the putative class of broiler chicken farmers all claims raised in this consolidated action on terms not material to the Company for which the Company recorded an accrual in its Consolidated Financial Statements as of October 2, 2021. The Court granted preliminary approval of the settlement on August 23, 2021 and final approval on February 18, 2022, and the Company paid the settlement during fiscal 2022. The DOJ’s Antitrust Division opened a civil investigation into broiler chicken grower contracts and alleged non-competitive practices involving performance-based compensation sharing for the purpose of stabilizing compensation below competitive levels. We continue to cooperate with the investigation.

Pork Antitrust Litigation

Beginning June 18, 2018, a series of putative class action complaints were filed against us and certain of our pork subsidiaries, as well as several other pork processing companies, in the United States District Court for the District of Minnesota styled In re Pork Antitrust Litigation (the “Pork Antitrust Civil Litigation”). The plaintiffs allege, among other things, that beginning in January 2009, the defendants conspired and combined to fix, raise, maintain, and stabilize the price of pork and pork products in violation of federal antitrust laws. The complaints on behalf of the putative classes of indirect purchasers also include causes of action under various state unfair competition laws, consumer protection laws, and unjust enrichment common laws. The plaintiffs seek treble damages, injunctive relief, pre- and post-judgment interest, costs, and attorneys’ fees on behalf of the putative classes. Since the original filing, certain putative class members have opted out of the matter and are proceeding with individual direct actions making similar claims, and others may do so in the future. The Company has not recorded any liability for this matter as it does not believe a loss is probable or reasonably estimable because the Company believes that it has valid and meritorious defenses against the allegations.

The Offices of the Attorney General in New Mexico and Alaska have filed complaints against us and certain of our pork subsidiaries, as well as several other pork processing companies and Agri Stats. The complaints are based on allegations similar to those asserted in the Pork Antitrust Civil Litigation and allege violations of state antitrust, unfair trade practice, and unjust enrichment laws based on allegations of conspiracies to exchange information and manipulate the supply of pork. The Company has not recorded any liability for the foregoing matters as it does not believe a loss is probable or reasonably estimable at this time.

Beef Antitrust Litigation

On April 23, 2019, a putative class action complaint was filed against us and our beef and pork subsidiary, Tyson Fresh Meats, Inc. (“Tyson Fresh Meats”), as well as other beef packer defendants, in the United States District Court for the Northern District of Illinois. The plaintiffs allege that the defendants engaged in a conspiracy from January 2015 to the present to reduce fed cattle prices in violation of federal antitrust laws, the Grain Inspection, Packers and Stockyards Act of 1921, and the Commodities Exchange Act by periodically reducing their slaughter volumes so as to reduce demand for fed cattle, curtailing their purchases and slaughters of cash-purchased cattle during those same periods, coordinating their procurement practices for fed cattle settled on a cash basis, importing foreign cattle at a loss so as to reduce domestic demand, and closing and idling plants. In addition, the plaintiffs also allege the defendants colluded to manipulate live cattle futures and options traded on the Chicago Mercantile Exchange. The plaintiffs seek, among other things, treble monetary damages, punitive damages, restitution, and pre- and post-judgment interest, as well as declaratory and injunctive relief. Other similar lawsuits were filed by cattle ranchers in other district courts which were then transferred to the United States District Court for the District of Minnesota and consolidated and styled as In Re Cattle Antitrust Litigation. On February 18, 2021, we moved to dismiss the amended complaints, and on September 14, 2021, the court granted the motion with respect to certain state law claims but denied the motion with respect to the plaintiffs’ federal antitrust claims. The Company has not recorded any liability for this matter as it does not believe a loss is probable or reasonably estimable at this time because the Company believes that it has valid and meritorious defenses against the allegations and because the classes have not yet been defined or certified by the court.

On April 26, 2019, a putative class of indirect purchasers filed a class action complaint against us, other beef packers, and Agri Stats in the United States District Court for the District of Minnesota. The plaintiffs allege that the packer defendants conspired to reduce slaughter capacity by closing or idling plants, limiting their purchases of cash cattle, coordinating their procurement of cash cattle, and reducing their slaughter numbers so as to reduce beef output, all in order to artificially raise prices of beef. The plaintiffs seek, among other things, damages under state antitrust and consumer protection statutes and the common law of approximately 30 states, as well as injunctive relief. The indirect consumer purchaser litigation is styled Peterson v. JBS USA Food Company Holdings, et al. Additional complaints have been filed on behalf of a putative class of direct purchasers of beef containing allegations of violations of Section 1 of the Sherman Act based on an alleged conspiracy to artificially fix, raise, and stabilize the wholesale price for beef, as well as on behalf of a putative class of commercial and institutional indirect purchasers of beef containing allegations of violations of Section 1 of the Sherman Act, various state antitrust laws and unjust enrichment based on an alleged conspiracy to artificially inflate the price for beef. On February 18, 2021, we moved to dismiss the plaintiffs’ amended complaints, and on September 14, 2021, the court granted the motion with respect to certain state law claims but denied the motion with respect to the plaintiffs’ federal antitrust claims. Since the original filing, certain putative class members have opted out of the matter and are proceeding with individual direct actions making similar claims, and others may do so in the future. The Company has not recorded any liability for this matter as it does not believe a loss is probable or reasonably estimable at this time because the Company believes that it has valid and meritorious defenses against the allegations and because the classes have not yet been defined or certified by the court.

On February 18, 2022, a putative class action was commenced against us, Tyson Fresh Meats, and other beef packer defendants in the Supreme Court of British Columbia styled Bui v. Cargill, Incorporated et al. The plaintiff alleges that the defendants conspired to fix, maintain, increase, or control the price of beef, as well as to fix, maintain, control, prevent, or lessen the production or supply of beef by agreeing to reduce the number of cattle slaughtered, reduce slaughter capacity, refrain from increasing slaughter and beef processing capacity, limit purchases of cattle on the cash market, and coordinate purchases of and bids for cattle to lower the supply of fed cattle. The plaintiff advances causes of action under the Competition Act, civil conspiracy, unjust enrichment, and the Civil Code of Québec. The plaintiff seeks to certify a class comprised of all persons or entities in Canada who directly or indirectly purchased beef in Canada, either for resale or for their own consumption between January 1, 2015, and the present and seeks declarations regarding the alleged conspiracy, general damages, aggravated, exemplary, and punitive damages, injunctive relief, costs, and interest. On March 24, 2022, a putative class action was commenced against the same defendants in the Superior Court of Québec styled De Bellefeuille v. Cargill, Incorporated et al. The plaintiff is making substantially the same allegations as those made in the British Columbia action. On behalf of the putative class of persons who purchased beef in Québec since January 1, 2015, the plaintiff is seeking compensatory damages, costs of investigation and interest. The Company has not recorded any liability for the foregoing matters as it does not believe a loss is probable or reasonably estimable at this time because the proceedings are in preliminary stages.

On October 31, 2022, a class action complaint was filed on behalf of putative classes of indirect cattle producers against us, Tyson Fresh Meats, and other beef packer defendants in the United States District Court for the District of Kansas. The plaintiffs allege that the defendants engaged in a conspiracy in violation of Section 1 of the Sherman Act, the Packers and Stockyards Act of 1921 and various state unfair competition and consumer protection laws from January 2015 to the present to reduce the price of cows, cattle, calves, steers or heifers by periodically reducing their slaughter volumes so as to reduce demand for fed cattle, curtailing their purchases and slaughters of cash-purchased cattle during those same periods, coordinating their procurement practices for fed cattle settled on a cash basis, importing foreign cattle at a loss so as to reduce domestic demand, and closing and idling plants. The plaintiffs seek, among other things, treble monetary damages, punitive damages, restitution, and pre- and post-judgment interest under state antitrust and consumer protection statutes and the common law of approximately 33 states, as well as declaratory and injunctive relief. The indirect producer litigation is styled Sprecht et. al. v. Tyson, Inc., et al. In November 2022, the case was transferred and consolidated with In re Cattle and Beef Antitrust Litigation, MDL No. 3031. On February 3, 2023, we moved to dismiss the complaint, and the court granted the motion on August 17, 2023 but later permitted the plaintiffs to amend their complaint. The Company has not recorded any liability for this matter as it does not believe a loss is probable or reasonably estimable at this time because the Company believes that it has valid and meritorious defenses against the allegations and because the classes have not yet been defined or certified by the court.

On May 22, 2020, December 23, 2020 and October 29, 2021, we received civil investigative demands (“CIDs”) from the DOJ’s Civil Antitrust Division. The CIDs request information related to the fed cattle and beef packing markets. We have been cooperating with the DOJ with respect to the CIDs. The Offices of the Attorney General for multiple states are participating in the investigation and coordinating with the DOJ.

We received a subpoena dated April 21, 2022 from the New York Attorney General’s Bureau of Consumer Frauds & Protection seeking information regarding our sales, prices and production costs of beef, pork and chicken products. After we had made an initial production of information, we were unable to agree with the New York Attorney General's office on the appropriate scope of the subpoena. Following initial litigation on the scope of the subpoena, we are reviewing and producing documents.

Wage Rate Litigation

On August 30, 2019, a putative class of non-supervisory production and maintenance employees at chicken processing plants in the continental United States filed class action complaints against us and certain of our subsidiaries, as well as several other poultry processing companies, in the United States District Court for the District of Maryland. The plaintiffs allege that the defendants directly and through a wage survey and benchmarking service exchanged information regarding labor rates in an effort to depress and fix the rates of wages for non-supervisory production and maintenance workers in violation of federal antitrust laws. The plaintiffs seek, among other things, treble monetary damages, punitive damages, restitution, and pre- and post-judgment interest, as well as declaratory and injunctive relief. Additional lawsuits making similar allegations were consolidated including an amended consolidated complaint containing additional allegations concerning turkey processing plants naming additional defendants. We moved to dismiss the amended consolidated complaint. On September 16, 2020, the court dismissed claims against us and certain other defendants without prejudice because the complaint improperly grouped together corporate subsidiaries. The court otherwise denied the defendants’ motions to dismiss and sustained claims based on alleged conspiracies to fix wages and exchange information against five other defendants. The plaintiffs filed a second amended consolidated complaint on November 2, 2020. We moved to dismiss the complaint on December 18, 2020 based on a lack of standing to assert claims on behalf of the purported class. The court denied the motion to dismiss on March 10, 2021. On February 16, 2022, the plaintiffs filed a third amended consolidated complaint naming additional poultry processors as defendants and expanding the scope of the claims to include employees at hatcheries and feed mills. We moved to dismiss the claims related to hatchery and feed mill employees. The court denied the motion to dismiss on July 19, 2022. In the third quarter of fiscal 2021, the Company recorded an accrual for the estimated probable losses that it expects to incur for this matter in the Company’s Consolidated Financial Statements. There was no change to the accrual in fiscal 2023.

The DOJ’s Antitrust Division has opened a civil investigation into human resources at several poultry companies. We are cooperating with the investigation.

On November 11, 2022, a putative class of employees at beef-processing and pork-processing plants in the continental United States filed a class action complaint against us and certain of our subsidiaries, as well as several other beef-processing and pork-processing companies, in the United States District Court for the District of Colorado. The plaintiffs allege that the defendants directly and through a wage survey and benchmarking service exchanged information regarding labor rates in an effort to depress and fix the rates of wages for employees in violation of federal antitrust laws. The plaintiffs seek, among other things, treble monetary damages, punitive damages, restitution, and pre- and post-judgment interest, as well as declaratory and injunctive relief. On February 17, 2023, we moved to dismiss the complaint, and on September 27, 2023, the court denied our motion. The Company has not recorded any liability for this matter as it does not believe a loss is probable or reasonably estimable at this time because the Company believes that it has valid and meritorious defenses against the allegations and because the case remains at the pleading stage and the classes have not yet been defined or certified by the court.

Other Matters

Our subsidiary, The Hillshire Brands Company (formerly named Sara Lee Corporation), is a party to a consolidation of cases filed by individual complainants with the Republic of the Philippines, Department of Labor and Employment and the National Labor Relations Commission (“NLRC”) from 1998 through July 1999. The complaint was filed against Aris Philippines, Inc., Sara Lee Corporation, Sara Lee Philippines, Inc., Fashion Accessories Philippines, Inc., and Attorney Cesar C. Cruz (collectively, the “respondents”). The complaint alleges, among other things, that the respondents engaged in unfair labor practices in connection with the termination of manufacturing operations in the Philippines in 1995 by Aris Philippines, Inc., a former subsidiary of The Hillshire Brands Company. In late 2004, a labor arbiter ruled against the respondents and awarded the complainants approximately $ i 61 million in damages and fees. From 2004 through 2014, the parties filed numerous appeals, motions for reconsideration and petitions for review, certain of which remained outstanding for several years. On December 15, 2016, we learned that the NLRC rendered its decision on November 29, 2016, regarding the respondents’ appeals from the labor arbiter’s 2004 ruling in favor of the complainants. The NLRC increased the award for i 4,922 of the total i 5,984 complainants to approximately $ i 262 million. However, the NLRC approved a prior settlement reached with the group comprising approximately i 18% of the class of i 5,984 complainants, pursuant to which The Hillshire Brands Company agreed to pay each settling complainant approximately $ i 1,200. The parties filed numerous appeals, motions for reconsideration and petitions for review related to the NLRC award and settlement payment. The Court of Appeals subsequently vacated the NLRC’s award on April 12, 2018. Complainants have filed motions for reconsideration with the Court of Appeals which were denied. Claimants have since filed petitions for writ of certiorari with the Supreme Court of the Philippines, which has accepted. The Company continues to maintain an accrual for estimated probable losses for this matter in the Company’s Consolidated Financial Statements.

Various claims have been asserted against the Company, its subsidiaries, and its officers and agents by, and on behalf of, team members who claim to have contracted COVID-19 in our facilities. The Company has not recorded any liability for these matters as it does not believe a loss is probable or reasonably estimable at this time because it believes the allegations in the claims are without merit.

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of Tyson Foods, Inc.

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Tyson Foods, Inc. and its subsidiaries (the “Company”) as of September 30, 2023 and October 1, 2022, and the related consolidated statements of income, of comprehensive income, of shareholders' equity and of cash flows for the fiscal years ended September 30, 2023, October 1, 2022 and October 2, 2021, including the related notes and the schedule of valuation and qualifying accounts for the fiscal years ended September 30, 2023, October 1, 2022 and October 2, 2021 appearing under Item 15 (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of September 30, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of September 30, 2023 and October 1, 2022, and the results of its operations and its cash flows for the fiscal years ended September 30, 2023, October 1, 2022 and October 2, 2021 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of September 30, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Annual Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Third and Fourth Quarter Interim Goodwill Impairment Assessments – Certain Reporting Units in the Chicken, Beef and Pork Segments and in International/Other

As described in Notes 1 and 5 to the consolidated financial statements, the Company’s consolidated goodwill balance was $9,878 million as of September 30, 2023, which included $3,064 million, $343 million, $423 million and $144 million for reporting units in the Chicken, Beef and Pork segments and in International/Other, respectively. Goodwill is reviewed for impairment at least annually or more frequently if impairment indicators arise. If it is determined, based on qualitative factors, the fair value of the reporting unit may more likely than not be less than carrying amount, a quantitative goodwill impairment test is performed. Management estimates the fair value of reporting units considering the use of various valuation techniques, with the primary technique being an income approach (discounted cash flow method) and another technique being a market approach (guideline public company method). The determination of fair value using these techniques includes assumptions about sales growth, operating margins, discount rates and valuation multiples which consider budgets, business plans, economic projections and marketplace data. During the third quarter of fiscal 2023, the Company experienced lower than anticipated operating results and changing market fundamentals, as well as a drop in its market capitalization to below book value. Consequently, management performed an interim assessment of goodwill and recorded a $448 million goodwill impairment charge, of which $210 million and $238 million was recognized in the Chicken segment and International/Other, respectively. Management performed its annual impairment test as of the first day of the fourth quarter in fiscal 2023, and it did not result in an additional goodwill impairment. During the fourth quarter of fiscal 2023, long-term treasury rates increased, which caused an increase in the discount rates used in estimating the fair value of the reporting units. Consequently, management determined it was necessary to perform a quantitative assessment for the Beef, Pork and two of the Chicken segment reporting units as of September 30, 2023, and management recognized a $333 million goodwill impairment charge related to the Beef reporting unit.

The principal considerations for our determination that performing procedures relating to the third and fourth quarter interim goodwill impairment assessments of certain reporting units in the Chicken, Beef and Pork segments and in International/Other is a critical audit matter are (i) the significant judgment by management when developing the fair value estimates of the reporting units; (ii) a high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating management’s significant assumptions related to (a) for the third quarter interim impairment assessment: sales growth, operating margins, and discount rates used in the discounted cash flow method for the Beef, Pork and certain Chicken and International/Other reporting units, and valuation multiples used in the guideline public company method for certain Chicken and International/Other reporting units and (b) for the fourth quarter interim impairment assessment: operating margins and discount rates used in the discounted cash flow method for the Beef reporting unit; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of the Company’s controls relating to management’s third and fourth quarter interim goodwill impairment assessments, including controls over the valuation of certain reporting units in the Chicken, Beef and Pork segments and in International/Other. These procedures also included, among others, as applicable to the reporting units and interim impairment assessments described above, (i) testing management’s process for developing the fair value estimates of certain reporting units in the Chicken, Beef and Pork segments and in International/Other; (ii) evaluating the appropriateness of the income and market valuation approaches, as applicable; (iii) testing the completeness and accuracy of underlying data used in the valuation approaches; and (iv) evaluating the reasonableness of management’s significant assumptions related to sales growth, operating margins, discount rates and valuation multiples, as applicable. Evaluating management’s assumptions related to sales growth, operating margins, discount rates and valuation multiples involved evaluating whether the assumptions used were reasonable considering (i) the current and past performance of the reporting units; (ii) the consistency with external market and industry data; and (iii) whether the assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in evaluating (i) the appropriateness of the Company’s valuation approaches and (ii) the reasonableness of the sales growth, discount rates and valuation multiples significant assumptions, as applicable to the reporting units and interim impairment assessments described above.

/s/ i PricewaterhouseCoopers LLP

i Springdale, Arkansas

We have served as the Company’s auditor since 2009.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

Not applicable.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

An evaluation was performed, under the supervision and with the participation of management, including the Chief Executive Officer (“CEO”) and the Chief Financial Officer (“CFO”), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “1934 Act”)). Based on that evaluation, the CEO and CFO concluded that, as of September 30, 2023, our disclosure controls and procedures were effective.

Management’s Annual Report on Internal Control Over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) and 15d-15(f) of the 1934 Act. Our internal control over financial reporting was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

Management conducted an evaluation of the effectiveness of our internal control over financial reporting as of September 30, 2023. In making this assessment, we used criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control - Integrated Framework (2013). Based on this evaluation under the framework in Internal Control - Integrated Framework (2013) issued by COSO, management concluded the Company’s internal control over financial reporting was effective as of September 30, 2023.

The Company’s independent registered public accounting firm, PricewaterhouseCoopers LLP, who has audited the fiscal 2023 financial statements included in this Annual Report on Form 10-K, has also audited the effectiveness of the Company’s internal control over financial reporting as of September 30, 2023 as stated in its report which appears in Part II, Item 8 of this Annual Report on Form 10-K.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the 1934 Act) during the quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

Rule 10b5-1 Trading Plans

During the three months ended September 30, 2023, none of the Company’s directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

See information set forth under the captions “Election of Directors” and “Board of Directors and Corporate Governance Information” in the Company’s definitive Proxy Statement for the Company’s Annual Meeting of Shareholders to be held February 8, 2024 (the “Proxy Statement”), which information is incorporated herein by reference. Pursuant to general instruction G(3) of Annual Report on Form 10-K, certain information concerning our executive officers is included under the caption “Information About Our Executive Officers” in Part I of this Annual Report on Form 10-K. The information required by this item regarding delinquent filers pursuant to Item 405 of Regulation S-K will be included under the caption “Delinquent Section 16(a) Reports” in the Proxy Statement and is incorporated by reference herein.

We have a code of ethics as defined in Item 406 of Regulation S-K, which applies to all of our directors and team members, including our principal executive officer, principal financial officer, principal accounting officer or controller, and persons performing similar functions. This code of ethics, titled “Tyson Code of Conduct,” is available, free of charge on our website at http://ir.tyson.com.

We will post any amendments to the Code of Conduct, and any waivers that are required to be disclosed by the rules of either the SEC or the New York Stock Exchange, on our website.

ITEM 11. EXECUTIVE COMPENSATION

See the information set forth under the captions “Executive Compensation,” “Director Compensation For Fiscal Year 2023,” “Compensation Discussion and Analysis,” “Report of the Compensation and Leadership Development Committee” and “Compensation Committee Interlocks and Insider Participation” in the Proxy Statement, which information is incorporated herein by reference. However, pursuant to instructions to Item 407(e)(5) of Regulation S-K, the material appearing under the sub-heading “Report of the Compensation and Leadership Development Committee” shall be deemed “furnished” and not be deemed to be “filed” with the SEC, other than as provided in this Item 11.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

See the information included under the captions “Security Ownership of Certain Beneficial Owners” and “Security Ownership of Management” in the Proxy Statement, which information is incorporated herein by reference.

Securities Authorized for Issuance Under Equity Compensation Plans

The following information reflects certain information about our equity compensation plans as of September 30, 2023:


	Equity Compensation Plan Information
	Number of Securities to be issued upon exercise of outstanding options	Weighted average exercise price of outstanding options		Number of Securities remaining available for future issuance under equity compensation plans (excluding Securities reflected in the first column (a))
Equity compensation plans approved by security holders	6,380,008	$	67.65	22,571,688
Equity compensation plans not approved by security holders	—	—		—
Total	6,380,008	$	67.65	22,571,688

(a) Shares of Class A Common Stock available for future issuance as of September 30, 2023, under the Stock Incentive Plan (6,923,370), the Employee Stock Purchase Plan (8,000,710) and the Retirement Savings Plan (7,647,608).

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

See the information included under the captions “Election of Directors,” “Board of Directors and Corporate Governance Information” and “Certain Transactions” in the Proxy Statement, which information is incorporated herein by reference.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

See the information included under the captions “Audit Fees,” “Audit-Related Fees,” “Tax Fees,” “All Other Fees,” and “Audit Committee Pre-Approval Policy” in the Proxy Statement, which information is incorporated herein by reference.

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(a)The following documents are filed as a part of this report:

(1) Consolidated Financial Statements

Consolidated Statements of Income for the three years ended September 30, 2023

Consolidated Statements of Comprehensive Income for the three years ended September 30, 2023

Consolidated Balance Sheets at September 30, 2023, and October 1, 2022

Consolidated Statements of Shareholders’ Equity for the three years ended September 30, 2023

Consolidated Statements of Cash Flows for the three years ended September 30, 2023

Notes to Consolidated Financial Statements

Report of Independent Registered Public Accounting Firm (PCAOB ID i 238)

(2) Consolidated Financial Statement Schedules

Financial Statement Schedule - Schedule II Valuation and Qualifying Accounts for the three years ended September 30, 2023

All other schedules are omitted because they are neither applicable nor required.

(3) Exhibits required by Item 601 of Regulation S-K

EXHIBIT INDEX

Exhibit No.


3.1						Restated Certificate of Incorporation of the Company (previously filed as Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended October 3, 1998, and incorporated herein by reference).

3.2						Sixth Amended and Restated By-Laws of the Company (previously filed as Exhibit 3.1 to the Company's Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 12, 2020, and incorporated herein by reference).

4.1						Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (previously filed as Exhibit 4.1 to the Company's Annual Report on Form 10-K for the period ended September 28, 2019, and incorporated herein by reference).

4.2						Indenture dated June 1, 1995, by and between the Company and The Chase Manhattan Bank, N.A., as Trustee (the “Company Indenture”) (previously filed as Exhibit 4 to Registration Statement on Form S-3, filed with the Commission on December 18, 1997, Registration No. 333-42525, and incorporated herein by reference).

4.3						Form of 7.0% Note due January 15, 2028, issued under the Company Indenture (previously filed as Exhibit 4.2 to the Company’s Quarterly Report on Form 10-Q for the period ended December 27, 1997, and incorporated herein by reference).

4.4						Supplemental Indenture dated as of June 13, 2012, by and between the Company and The Bank of New York Mellon Trust Company, National Association (as successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank, N.A.)), as Trustee, supplementing the Company Indenture (previously filed as Exhibit 4.1 to the Company's Current Report on Form 8-K filed June 13, 2012, and incorporated herein by reference).

4.5						Supplemental Indenture dated as of August 8, 2014, by and between the Company and The Bank of New York Mellon Trust Company, National Association (as successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank, N.A.)), as Trustee, supplementing the Company Indenture (previously filed as Exhibit 4.2 to the Company's Current Report on Form 8-K filed August 8, 2014, and incorporated herein by reference).

4.6						Supplemental Indenture dated as of August 8, 2014, by and between the Company and The Bank of New York Mellon Trust Company, National Association (as successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank, N.A.)), as Trustee, supplementing the Company Indenture (previously filed as Exhibit 4.4 to the Company's Current Report on Form 8-K filed August 8, 2014, and incorporated herein by reference).

4.7						Form of 3.95% Senior Note due 2024 (included in Exhibit 4.4 to the Company's Current Report on Form 8‑K filed August 8, 2014, and incorporated herein by reference).

4.8						Supplemental Indenture dated as of August 8, 2014, by and between the Company and The Bank of New York Mellon Trust Company, National Association (as successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank, N.A.)), as Trustee, supplementing the Company Indenture (previously filed as Exhibit 4.6 to the Company's Current Report on Form 8-K filed August 8, 2014, and incorporated herein by reference).

4.9						Form of 4.875% Senior Note due 2034 (included in Exhibit 4.6 to the Company's Current Report on Form 8‑K filed August 8, 2014, and incorporated herein by reference).

4.10						Supplemental Indenture dated as of August 8, 2014, by and between the Company and The Bank of New York Mellon Trust Company, National Association (as successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank, N.A.)), as Trustee, supplementing the Company Indenture (previously filed as Exhibit 4.8 to the Company's Current Report on Form 8-K filed August 8, 2014, and incorporated herein by reference).

4.11						Form of 5.15% Senior Note due 2044 (previously filed as Exhibit 4.8 to the Company's Current Report on Form 8‑K filed August 8, 2014, and incorporated herein by reference).

4.12						Indenture dated October 2, 1990, between Sara Lee Corporation and Continental Bank, N.A., as Trustee (the “Sara Lee Indenture”) (previously filed as Exhibit 4.1 to Amendment No. 1 to Registration Statement No. 33-33603 on Form S-3 by Sara Lee Corporation, predecessor in interest to The Hillshire Brands Company, filed with the Commission on October 5, 1990, and incorporated herein by reference).

4.13						Form of 61/8% Notes due 2032 issued pursuant to the Sara Lee Indenture (previously filed as Exhibit 4.25 to the Company’s Annual Report on Form 10-K for the fiscal year ended September 27, 2014, and incorporated herein by reference).

4.14						Supplemental Indenture dated June 2, 2017, by and between the Company and The Bank of New York Mellon Trust Company, N.A. (as successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank, N.A.)), as Trustee, supplementing the Company Indenture (previously filed as Exhibit 4.2 to the Company's Current Report on Form 8-k filed on June 2, 2017, and incorporated herein by reference).

4.15						Supplemental Indenture dated June 2, 2017, by and between the Company and The Bank of New York Mellon Trust Company, N.A. (as successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank, N.A.)), as Trustee, supplementing the Company Indenture (previously filed as Exhibit 4.4 to the Company's Current Report on Form 8-K filed on June 2, 2017, and incorporated herein by reference).


4.16		Supplemental Indenture dated June 2, 2017, by and between the Company and The Bank of New York Mellon Trust Company, N.A. (as successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank, N.A.)), as Trustee, supplementing the Company Indenture (previously filed as Exhibit 4.6 to the Company's Current Report on Form 8-K filed on June 2, 2017, and incorporated herein by reference).

4.17		Form of 3.55% Senior Notes due 2027 (previously filed as Exhibit 4.6 to the Company's Current Report on Form 8-K filed on June 2, 2017, and incorporated herein by reference).

4.18		Supplemental Indenture dated June 2, 2017, by and between the Company and The Bank of New York Mellon Trust Company, N.A. (as successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank, N.A.)), as Trustee, supplementing the Company Indenture (previously filed as Exhibit 4.8 to the Company's Current Report on Form 8-K filed on June 2, 2017, and incorporated herein by reference).

4.19		Form of 4.55% Senior Notes due 2047 (previously filed as Exhibit 4.8 to the Company's Current Report on Form 8-K filed on June 2, 2017, and incorporated herein by reference).

4.20		Supplemental Indenture, dated September 28, 2018, by and between the Company and the Bank of New York Mellon Trust Company, N.A. (as successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank, N.A.)), as Trustee, supplementing the Company Indenture (previously filed as exhibit 4.2 to the Company's Current Report on Form 8-K filed on September 28, 2018, and incorporated herein by reference.

4.21		Supplemental Indenture, dated September 28, 2018, by and between the Company and the Bank of New York Mellon Trust Company, N.A. (as successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank, N.A.)), as Trustee, supplementing the Company Indenture (previously filed as exhibit 4.4 to the Company’s Current Report on Form 8-K filed on September 28, 2018, and incorporated herein by reference.

4.22		Form of 5.100% Senior Notes due 2048 (previously filed as Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on September 28, 2018, and incorporated herein by reference).

10.1		Revolving Credit Agreement, dated September 30, 2021, among Tyson Foods, Inc., the subsidiary borrowers party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on October 4, 2021, and incorporated herein by reference).

10.2	**	First Amendment to the Revolving Credit Agreement, dated as of November 9, 2022, among Tyson Foods, Inc. and JPMorgan Chase Bank, N.A., as administrative agent (previously filed as Exhibit 10.2 to the Company's Annual Report on Form 10-K for the fiscal year ended October 1, 2022 , and incorporated herein by reference).

10.3	*	Term Loan Agreement, dated May 3, 2023, among Tyson Foods, Inc., the lenders party thereto, Bank of America, N.A. as administrative agent, and BofA Securities Inc. as lead arranger (previously filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the period ended April 1, 2023, and incorporated herein by reference).

10.4	*	Term Loan Agreement, dated May 3, 2023, among Tyson Foods, Inc., the lenders party thereto, CoBank ACB, as administrative agent, and CoBank FCB, as sole lead arranger (previously filed as Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the period ended April 1, 2023, and incorporated herein by reference).

10.5	*	Second Amended and Restated Employment Agreement, dated November 9, 2017, by and between the Company and John Tyson (previously filed as Exhibit 10.76 to the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2017, and incorporated herein by reference).

10.6	*	Employment Agreement, effective as of June 2, 2021, by and between the Company and Donnie King (previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 2, 2021, and incorporated herein by reference).

10.7	*	Compensatory arrangement by and between the Company and John Randal Tyson (previously filed as Exhibit 10.17 to the Company’s Current Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.8	*	Release Agreement dated as of January 17, 2023 between Tyson Foods, Inc. and Scott Spradley (previously filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.9	*	Offer letter between Tyson Foods, Inc. and Wes Morris (previously filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the period ended April 1, 2023, and incorporated herein by reference).

10.10	*	Offer letter between Tyson Foods, Inc. and Brady Stewart (previously filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the period ended April 1, 2023, and incorporated herein by reference).

10.11	*	Second Amended and Restated Employment Agreement dated as of October 2nd, 2020, entered into between the Company and Noel W. White (previously filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed October 8, 2020, and incorporated herein by reference).


10.12	*	Offer Letter between Tyson Foods, Inc. and Johanna Söderström (previously filed as Exhibit 10.11 to the Company’s Annual Report on Form 10-K for the fiscal year ended October 3, 2020, and incorporated herein by reference).

10.13	*	Indemnity Agreement, dated as of September 28, 2007, between the Company and John Tyson (previously filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed September 28, 2007, and incorporated herein by reference).

10.14	*	Form of Indemnity Agreement between Tyson Foods, Inc. and its directors and certain executive officers (previously filed as Exhibit 10.13 to the Company’s Annual Report on Form 10-K for the fiscal year ended October 3, 2020, and incorporated herein by reference).

10.15	*	Tyson Foods, Inc. Annual Incentive Compensation Plan for Senior Executives adopted February 4, 2005, and amended effective August 4, 2021 (previously filed as Exhibit 10.31 to the Company’s Quarterly Report on Form 10-Q for the fiscal period ended January 1, 2022, and incorporated herein by reference).

10.16	*	Amended and Restated Tyson Foods, Inc. Employee Stock Purchase Plan, effective as of February 1, 2013 (previously filed as Exhibit 99.2 to Registration Statement on Form S-8 on February 22, 2013, Registration No. 333-186797, and incorporated herein by reference).

10.17	*	First Amendment to the Tyson Foods, Inc. Employee Stock Purchase Plan, effective February 1, 2013 (previously filed as Exhibit 10.26 to the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2013, and incorporated herein by reference).

10.18	*	Amended and Restated Executive Savings Plan of Tyson Foods, Inc. effective January 1, 2013 (previously filed as Exhibit 10.27 to the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2013, and incorporated herein by reference).

10.19	*	First Amendment to the Executive Savings Plan of Tyson Foods, Inc. effective November 16, 2017 (previously filed as Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q for the quarter ended December 30, 2017, and incorporated herein by reference).

10.20	*	Tyson Foods, Inc. 2000 Stock Incentive Plan, amended and restated as of February 11, 2021 (previously filed as Exhibit A-1 to the Company’s Definitive Proxy Statement, filed with the Securities and Exchange Commission on December 23, 2020, and incorporated herein by reference).

10.21	*	Amended and Restated Tyson Foods, Inc. Supplemental Executive Retirement and Life Insurance Premium Plan effective January 1, 2017 (previously filed as Exhibit 10.68 to the Company’s Annual report on Form 10-K for the fiscal year ended October 1, 2016, and incorporated herein by reference).

10.22	*	First Amendment to the Tyson Foods, Inc. Supplemental Executive Retirement and Life Insurance Premium Plan effective November, 16, 2017 (previously filed as Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q for the quarter ended 12/30/2017, and incorporated herein by reference).

10.23	*	Second Amendment to the Tyson Foods, Inc. Supplemental Executive Retirement and Life Insurance Premium Plan effective February 2018 (previously filed as Exhibit 10.16 to the Company’s Quarterly Report on Form 10-Q for the quarter ended 12/30/2017, and incorporated herein by reference).

10.24	*	Retirement Savings Plan of Tyson Foods, Inc. effective January 1, 2011 (previously filed as Exhibit 10.33 to the Company’s Annual Report on Form 10-K for the fiscal year ended October 1, 2011, and incorporated herein by reference).

10.25	*	First Amendment to the Retirement Savings Plan of Tyson Foods, Inc., as Amended and Restated as of January 1, 2011 (previously filed as Exhibit 10.32 to the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2013, and incorporated herein by reference).

10.26	*	Amended and Restated Retirement Income Plan of IBP, inc. effective August 1, 2000, and Amendment to Freeze the Retirement Income Plan of IBP, inc. effective December 31, 2002 (previously filed as Exhibit 10.46 to the Company’s Annual Report on Form 10-K for the fiscal year ended September 27, 2008, and incorporated herein by reference).

10.27	*	Tyson Foods, Inc. Severance Pay Plan for Contracted Employees, as amended and restated effective December 1, 2017 (previously filed as Exhibit 10.15 to the Company’s Quarterly Report on Form 10-Q for the quarter ended December 30, 2017, and incorporated herein by reference).

10.28	*	Executive Severance Plan effective October 15, 2018 (previously filed as Exhibit 10.65 to the Company’s Annual Report on Form 10-K for the period ended September 29, 2018, and incorporated herein by reference).

10.29	*	Executive Severance Plan, as amended and restated effective February 15, 2020 (previously filed as Exhibit 10.4 to the Company’s Annual Report on Form 10-Q for the period ended January 1, 2022, and incorporated herein by reference).

10.30	*	Executive Severance Plan, as amended and restated effective October 1, 2023 (previously filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).


10.31	*	Form of Stock Options (Contracted) - Stock Incentive Award Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.32	*	Form of Stock Options (5+1) - Stock Incentive Award Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.33	*	Form of Stock Options (Director/Non-Contract) - Stock Incentive Award Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.34	*	Form of Stock Options (CEO & Other CT) - Stock Incentive Award Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.35	*	Form of Restricted Stock (Contracted) - Stock Incentive Award Agreement pursuant to which restricted share awards are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.36	*	Form of Restricted Stock (Director/Non-Contract) - Stock Incentive Award Agreement pursuant to which restricted share awards are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.8 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.37	*	Form of Restricted Stock (5+1) - Stock Incentive Award Agreement pursuant to which restricted share awards are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.9 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.38	*	Form of Performance Shares - Operating Income - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.10 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.39	*	Form of Performance Shares - Operating Income (5+1) - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.11 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.40	*	Form of Performance Shares - Total Shareholder Return - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.12 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.41	*	Form of Performance Shares - Total Shareholder Return (5+1) - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.13 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.42	*	Form of Performance Shares - Return on Invested Capital - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.14 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.43	*	Form of Performance Shares - Return on Invested Capital (5+1) - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. Stock Incentive Plan effective November 18, 2022 (previously filed as Exhibit 10.15 to the Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2022, and incorporated herein by reference).

10.44	*	Form of Performance Shares - Operating Income - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 17, 2017 (previously filed as Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the period ended December 29, 2018, and incorporated herein by reference).


10.45	*	Form of Performance Shares - Operating Income (5+1) - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 17, 2017 (previously filed as Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the period ended December 29, 2018, and incorporated herein by reference).

10.46	*	Form of Restricted Stock Subject to Performance Criteria - Stock Incentive Award Agreement pursuant to which restricted stock awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 17, 2017 (previously filed as Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q for the period ended December 29, 2018, and incorporated herein by reference).

10.47	*	Form of Restricted Stock Subject to Performance Criteria (5+1) - Stock Incentive Award Agreement pursuant to which restricted stock awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 17, 2017 (previously filed as Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q for the period ended December 29, 2018, and incorporated herein by reference).

10.48	*	Form of Stock Options (Contracted) - Stock Incentive Award Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 17, 2017 (previously filed as Exhibit 10.8 to the Company’s Quarterly Report on Form 10-Q for the period ended December 29, 2018, and incorporated herein by reference).

10.49	*	Form of Stock Options (5+1) - Stock Incentive Award Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 17, 2017 (previously filed as Exhibit 10.9 to the Company’s Quarterly Report on Form 10-Q for the period ended December 29, 2018, and incorporated herein by reference).

10.50	*	Form of Restricted Stock (Contracted) - Stock Incentive Award Agreement pursuant to which restricted stock awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 17, 2017 (previously filed as Exhibit 10.11 to the Company’s Quarterly Report on Form 10-Q for the period ended December 29, 2018, and incorporated herein by reference).

10.51	*	Form of Restricted Stock (Director/Non-contract) - Stock Incentive Award Agreement pursuant to which restricted share awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 17, 2017 (previously filed as Exhibit 10.12 to the Company’s Quarterly Report on Form 10-Q for the period ended December 29, 2018, and incorporated herein by reference).

10.52	*	Form of Restricted Stock (5+1) - Stock Incentive Award Agreement pursuant to which restricted stock awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 17, 2017 (previously filed as Exhibit 10.13 to the Company’s Quarterly Report on Form 10-Q for the period ended December 29, 2018, and incorporated herein by reference).

10.53	*	Form of Performance Shares - Total Shareholder Return - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 17, 2017 (previously filed as Exhibit 10.14 to the Company’s Quarterly Report on Form 10-Q for the period ended December 29, 2018, and incorporated herein by reference).

10.54	*	Form of Performance Shares - Total Shareholder Return (5+1) - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 17, 2017 (previously filed as Exhibit 10.15 to the Company’s Quarterly Report on Form 10-Q for the period ended December 29, 2018, and incorporated herein by reference).

10.55	*	Form of Stock Appreciation Rights Award Agreement pursuant to which stock appreciation rights are awarded under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 17, 2017 (previously filed as Exhibit 10.16 to the Company’s Quarterly Report on Form 10-Q for the period ended December 29, 2018, and incorporated herein by reference).

10.56	*	Form of Performance Shares - Operating Income - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.57	*	Form of Performance Shares - Operating Income (5+1) - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.58	*	Form of Performance Shares - Total Shareholder Return - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).


10.59	*	Form of Performance Shares - Total Shareholder Return (5+1) - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.60	*	Form of Restricted Stock Subject to Performance Criteria - Stock Incentive Award Agreement pursuant to which restricted stock awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.61	*	Form of Restricted Stock Subject to Performance Criteria (5+1) - Stock Incentive Award Agreement pursuant to which restricted stock awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.62	*	Form of Restricted Stock (Contracted) - Stock Incentive Award Agreement pursuant to which restricted share awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.63	*	Form of Restricted Stock (Director/Non-Contract) - Stock Incentive Award Agreement pursuant to which restricted share awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.8 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.64	*	Form of Restricted Stock (5+1) - Stock Incentive Award Agreement pursuant to which restricted stock awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.9 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.65	*	Form of Restricted Stock (International Director/Non-Contract) - Stock Incentive Award Agreement pursuant to which restricted share awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.10 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.66	*	Form of Restricted Stock (International Contracted) - Stock Incentive Award Agreement pursuant to which restricted share awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.11 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.67	*	Form of Stock Options (Contracted) - Stock Incentive Award Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.12 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.68	*	Form of Stock Options (5+1) - Stock Incentive Award Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.13 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.69	*	Form of Stock Options (Director/Non-Contract) - Stock Incentive Award Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 18, 2019 (previously filed as Exhibit 10.14 to the Company’s Quarterly Report on Form 10-Q for the period ended December 28, 2019, and incorporated herein by reference).

10.70	*	Form of Stock Options (Contracted) - Stock Incentive Award Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.71	*	Form of Stock Options (5+1) - Stock Incentive Award Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.72	*	Form of Stock Options (Director/Non-Contract) - Stock Incentive Award Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).


10.73	*	Form of Stock Options (CEO Special) - Stock Incentive Aware Agreement pursuant to which stock option awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective October 5, 2020 (previously filed as Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.74	*	Form of Restricted Stock (Contracted) - Stock Incentive Award Agreement pursuant to which restricted share awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.75	*	Form of Restricted Stock (Director/Non-Contract) - Stock Incentive Award Agreement pursuant to which restricted share awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.76	*	Form of Restricted Stock (5+1) - Stock Incentive Award Agreement pursuant to which restricted stock awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.77	*	Form of Performance Shares - Operating Income - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.8 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.78	*	Form of Performance Shares - Operating Income (5+1) - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.9 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.79	*	Form of Performance Shares - Total Shareholder Return - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.10 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.80	*	Form of Performance Shares - Total Shareholder Return (5+1) - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.11 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.81	*	Form of Restricted Stock (5+1 Special) - Stock Incentive Award Agreement pursuant to which restricted stock awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.12 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.82	*	Form of Restricted Stock (Contracted Special) - Stock Incentive Award Agreement pursuant to which restricted stock awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.13 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.83	*	Form of Restricted Stock (International Non-Contract) - Stock Incentive Award Agreement pursuant to which restricted share awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.14 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.84	*	Form of Restricted Stock (International Contracted) - Stock Incentive Award Agreement pursuant to which restricted share awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 20, 2020 (previously filed as Exhibit 10.15 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.85	*	Form of Restricted Stock (Chairman and CEO Special) - Stock Incentive Aware Agreement pursuant to which restricted stock awards are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective October 5, 2020 (previously filed as Exhibit 10.16 to the Company’s Quarterly Report on Form 10-Q for the period ended January 2, 2021, and incorporated herein by reference).

10.86		Form of Performance Shares – Return on Invested Capital (5+1) - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 19, 2021 (previously filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the period ended January 1, 2022, and incorporated herein by reference).

100


10.87		Form of Performance Shares – Return on Invested Capital (Contracted) - Stock Incentive Award Agreement pursuant to which performance shares are granted under the Tyson Foods, Inc. 2000 Stock Incentive Plan effective November 19, 2021 (previously filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the period ended January 1, 2022, and incorporated herein by reference).

19	**	Insider trading policy

21	**	Subsidiaries of the Company.

23	**	Consent of PricewaterhouseCoopers LLP.

31.1	**	Certification of Chief Executive Officer pursuant to SEC Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2	**	Certification of Chief Financial Officer pursuant to SEC Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1	***	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2	***	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

97	**	Clawback policy

101		The following financial information from our Annual Report on Form 10-K for the year ended September 30 2023, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Consolidated Statements of Income, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Shareholders’ Equity, (v) Consolidated Statements of Cash Flows, (vi) the Notes to Consolidated Financial Statements, and (vii) Financial Statement Schedule.

104		Cover Page Interactive Data File formatted in iXBRL.

*		Indicates a management contract or compensatory plan or arrangement.
**		Filed herewith
***		Furnished herewith

FINANCIAL STATEMENT SCHEDULE

TYSON FOODS, INC.

SCHEDULE II

VALUATION AND QUALIFYING ACCOUNTS

Fiscal year ended September 30, 2023, October 1, 2022 and October 2, 2021

Additions

in millions

Balance at
Beginning
of Period

Charged to
Costs and
Expenses

Charged to
Other
Accounts

(Deductions)

Balance at End
of Period

Allowance for Credit Losses:

2023

i 29

i 12

i —

( i 10)

i 31

2022

i 25

i 6

i —

( i 2)

i 29

2021

i 26

i 5

i —

( i 6)

i 25

Inventory Lower of Cost or Net Realizable Value Allowance:

2023

i 60

i 333

i —

( i 248)

i 145

2022

i 47

i 36

i —

( i 23)

i 60

2021

i 27

i 79

i —

( i 59)

i 47

Valuation Allowance on Deferred Tax Assets:

2023

i 195

i 4

i —

i 199

2022

i 151

i 44

i —

i 195

2021

i 127

i 24

i —

i 151

101

ITEM 16. Form 10-K Summary

None.

102

SIGNATURES

Pursuant to requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TYSON FOODS, INC.

By:

/s/ John R. Tyson

John R. Tyson

Executive Vice President and Chief Financial Officer (Principal Financial Officer)

By:

/s/ Phillip W. Thomas

Phillip W. Thomas

Vice President, Controller and Chief Accounting Officer (Principal Accounting Officer)

103

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

/s/ John H. Tyson

Chairman of the Board of Directors

John H. Tyson

/s/ Les R. Baledge

Director

Les R. Baledge

/s/ Mike Beebe

Director

Mike Beebe

/s/ Maria Claudia Borras

Director

Maria Claudia Borras

/s/ David J. Bronczek

Director

David J. Bronczek

/s/ Mikel A. Durham

Director

Mikel A. Durham

/s/ Donnie King

President, Chief Executive Officer, and Director

Donnie King

(Principal Executive Officer)

/s/ Jonathan D. Mariner

Director

Jonathan D. Mariner

/s/ Kevin M. McNamara

Vice Chairman of the Board of Directors

Kevin M. McNamara

/s/ Cheryl S. Miller

Director

Cheryl S. Miller

/s/ Jeffrey K. Schomburger

Director

Jeffrey K. Schomburger

/s/ Phillip W. Thomas

Vice President, Controller and Chief Accounting Officer

Phillip W. Thomas

(Principal Accounting Officer)

/s/ Barbara A. Tyson

Director

Barbara A. Tyson

/s/ John R. Tyson

Executive Vice President and Chief Financial Officer

John R. Tyson

(Principal Financial Officer)

/s/ Noel White

Executive Vice Chairman of the Board of Directors